Psyllid ID: psy742


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710---
MNREKKKMMRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLLET
ccHHHHccEEEEEEcccEEEEEEEEEEEEEEEEEEcccEEEEEEEccccccEEEEEEEEEcccEEEcEEEEEEEEccccccccEEEEEEEEEEcccccccccccccccccccccccccHHHccccHHHHHHHHccccccccccccccccEEEEEcccccccccccccccEEHHHHHHHHHHHHccccHHHHHHHHHHHHHccccccEEEcccccccccccccccccccccccccEEEHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHccccEEEccccccccccccccccccccccccccccccEEHHHHHHHHHHHHcccccHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEccccccEEEEEEcccccccccEEEEcccccEEEEEEEccEEEEEEEEEEEEccccccccccccccEEEEEEEEcccccccEEEEEEEEEEEEccccccccEEEEEcccccccccccccHHHHHcccccccccEEEEEccEEEEEEEcccccEEEEEEEEEEEEEEccccccEEEEEEEcccccccEEEEEEccccccccccccccccccccccccccccccccccEEEEEEEEEEEEEEccccEEEEEEHHHcccccEEEEEEEEEEEccccccccccccEEEEccccccc
cccccccEEEEEEccccccccEEEEEEEEccccccccccccccccccccccEEEEEEccccccccccHHHHHHHHHccccccccccHHHEEcccEEEEEHccccHHHHHccHHHHHHHHccccHHHHHHHHHHHHHcccEEEEEEcccccEEEEccccccccccHHHHHHHHHHHHHHHcccEEEEcHHHHHHHHHHHHHHcccccccccccccccHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHccccccHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHccccccccEEEEEEEccccccEEEEEEcccccEEEEEEEcccccccEEEEEEEcEEEEEEEEEEEEccccccccccccccEEEEEEEcccccccccEEEEEEEEEEEccccccccEEEEEEEcccccccccccHHHHHccccccEEEEEEEcccEEEEEEEEcccccEEEEEEEEEEEEccccccccEEEEEEcccccccEEEEEcccccccccHHHHcccccccccHHHHHHHHccccHHHHHHHHHHHHccccccHHHHHHHHccccccEEEEEEEEEEEccccccccccccHHEEEEEEEEcc
MNREKKKMMRIILLAGQENMQSTIRSFAVSLsaemapsaTIVVYNVgrngdviadsltfpvngisrnnvnaTVVFLpivpvhlgdidVTVTassligrdtvTRKLHIIadglpqhrHQSILLDLSNRAYVFQYLHVnvtetpiipydvdryyvygssinsssisTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVldhqtpdgsfyetTWLVDRkvnsslnwpnddvkfrniSLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQharseggltywgkepvpappskienqkpfllprlpykydaiNIETTAYALLVYVSRQELLTDPIVKwlnsqrltdggwasTQDTAMAMKALIEYTNrhrlrdvsyLTVSIEatalpgqvkyLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDiakfqtqppvpafalntranfhgrnqshityhSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTierwfpvanmsrylpirvydyyaperfnetifdALPTYLLNICevcgssqcpycpiynlavalscppvfFLSFFVLSVVfadglpqhrhQSILLDLSNRAYVFQYLHVnvtetpiipydvdryyVYGSTLLET
MNREKKKMMRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTAssligrdtVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNvtetpiipyDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFtierwfpvanmSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNvtetpiipydvdRYYVYGSTLLET
MNREKKKMMRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGssinsssisTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPvfflsffvlsvvfADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLLET
*********RIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGK*************KPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTL***
************************RSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDI**TVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVT*************************TLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDL**GL*****LAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEP*********NQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRA*****NQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLD************RARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTY*LNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLL**
********MRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLLET
****KKKMMRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLLET
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNREKKKMMRIILLAGQENMQSTIRSFAVSLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSSINSSSISTLKMLLWYSCLLCLYIWETLMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVLSVVFADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYYVYGSTLLET
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query713 2.2.26 [Sep-21-2011]
Q8R4221442 CD109 antigen OS=Mus musc yes N/A 0.740 0.366 0.25 2e-34
Q6YHK31445 CD109 antigen OS=Homo sap yes N/A 0.549 0.271 0.271 3e-32
Q8IZJ3 1885 C3 and PZP-like alpha-2-m no N/A 0.572 0.216 0.299 9e-32
Q618381495 Alpha-2-macroglobulin OS= no N/A 0.360 0.171 0.302 6e-25
Q630411500 Alpha-1-macroglobulin OS= no N/A 0.349 0.166 0.296 3e-23
P207401473 Ovostatin OS=Gallus gallu no N/A 0.514 0.249 0.256 8e-22
Q6IE521448 Murinoglobulin-2 OS=Rattu no N/A 0.520 0.256 0.249 3e-20
Q5R4N81474 Alpha-2-macroglobulin OS= no N/A 0.361 0.175 0.283 3e-20
P140461477 Alpha-1-inhibitor 3 OS=Ra no N/A 0.524 0.253 0.256 3e-20
P010231474 Alpha-2-macroglobulin OS= no N/A 0.394 0.190 0.266 6e-20
>sp|Q8R422|CD109_MOUSE CD109 antigen OS=Mus musculus GN=Cd109 PE=2 SV=1 Back     alignment and function desciption
 Score =  148 bits (373), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 162/648 (25%), Positives = 293/648 (45%), Gaps = 120/648 (18%)

Query: 34   EMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDVTVTAS 93
            E + S  I++ +   NG +   ++  P     R+N   T+VF PI P HLG+I +TVTA+
Sbjct: 787  EESDSFDILMTSNDTNGTIYRKTVQVP-----RDN-GVTLVF-PIKPTHLGEIPITVTAA 839

Query: 94   SLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVDRYY- 152
            S    D VT+ + +  +G+ +   +S+LLDL++     +   +  +  P      +R   
Sbjct: 840  SPTASDAVTQTIVVKPEGIEKSYSKSVLLDLTDSNVESKQQSMRFSFPPDTVIGSERVQI 899

Query: 153  -----VYGSSINSSSISTLKM--------LLWYS--CLLCLYIWETLMLPLQVITQAVSW 197
                 + GSSIN  S S ++M        +++++    +  Y+ +   L + +  +A+S+
Sbjct: 900  TAIGDILGSSINGLS-SLIRMPYGCGEQNMIYFAPNIYILDYLTKQKQLTVNLKEKALSY 958

Query: 198  V-------LDHQTPDGSFYE--------TTWL----------------VDRKV-NSSLNW 225
            +       L +Q  DGSF          +TWL                +D+ V + +  W
Sbjct: 959  MRQGYQRELLYQREDGSFSAFGDIDSSGSTWLSAFVLRCFLEADYYIDIDQDVLHRTYTW 1018

Query: 226  PNDDVKFRN--------------------ISLTAHVLITLDTVKDLTGGLGARVSLAQSK 265
             N   KF                      ++LTA+++ ++   K     +  +       
Sbjct: 1019 LNAHKKFNGEFWEPGRVIHSELQGGTKSPVTLTAYIVTSVLGYKKYQPNIDVQ------D 1072

Query: 266  AIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEP 325
            +IK+LE      +   D Y +AI++YAL    +  AE A  +L Q +  EG   +W    
Sbjct: 1073 SIKFLE--FEFSRGISDNYTLAIISYALSTVGSPKAEEALNLLMQRSEKEGDTQFW---- 1126

Query: 326  VPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQELLTDPIVKWLNSQRLTD 385
            + + P+   + +P           +++IE  AYALL +         P+++WL  QR + 
Sbjct: 1127 LSSGPALSGSWQP----------RSVDIEIAAYALLAHTLHHVSEGIPVMRWLIQQRNSL 1176

Query: 386  GGWASTQDTAMAMKALIEYTNR-HRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQR 444
            GG+ STQDT +A+KAL E++   H+      LTV+     +P  + +  + + NL  L +
Sbjct: 1177 GGFVSTQDTVVALKALSEFSALVHKENTDIQLTVT--GPGIPRSI-HFRIDSQNLFLLHQ 1233

Query: 445  IEIPQAWG--TVKVQASGAGYAILQMSVDYNVDIA----KFQTQPPVPAFALNTRANFHG 498
             E+  A    TV V A G+G+AI Q++VDYNV  +    + ++      F L+   N + 
Sbjct: 1234 EEL-HALDPITVNVSAHGSGFAICQLNVDYNVKGSGSSKRRRSTENQEVFDLDVIVN-NE 1291

Query: 499  RNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRARF 558
             + SH+  + C   +    S R+GM +++V + +G+      +           L++  +
Sbjct: 1292 DDISHLNLNVCTSHL---GSERTGMVLMEVNLLSGFSASSDSIPL------SETLKKVEY 1342

Query: 559  QEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYAPER 606
               K+  Y D +++++ C+N    R + V+N+ R   + V DYY P R
Sbjct: 1343 DNGKLNLYLDSVNESQFCVNIPTVRDYKVSNI-RDGSVSVMDYYEPRR 1389




Modulates negatively TGFB1 signaling in keratinocytes.
Mus musculus (taxid: 10090)
>sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 Back     alignment and function description
>sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 Back     alignment and function description
>sp|Q61838|A2M_MOUSE Alpha-2-macroglobulin OS=Mus musculus GN=A2m PE=1 SV=3 Back     alignment and function description
>sp|Q63041|A1M_RAT Alpha-1-macroglobulin OS=Rattus norvegicus GN=A1m PE=1 SV=1 Back     alignment and function description
>sp|P20740|OVOS_CHICK Ovostatin OS=Gallus gallus PE=1 SV=3 Back     alignment and function description
>sp|Q6IE52|MUG2_RAT Murinoglobulin-2 OS=Rattus norvegicus GN=Mug2 PE=1 SV=1 Back     alignment and function description
>sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii GN=A2M PE=2 SV=1 Back     alignment and function description
>sp|P14046|A1I3_RAT Alpha-1-inhibitor 3 OS=Rattus norvegicus GN=A1i3 PE=1 SV=1 Back     alignment and function description
>sp|P01023|A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query713
340722713 1626 PREDICTED: CD109 antigen [Bombus terrest 0.676 0.296 0.745 0.0
383857206 1628 PREDICTED: CD109 antigen-like [Megachile 0.666 0.291 0.754 0.0
242012592 1690 conserved hypothetical protein [Pediculu 0.676 0.285 0.731 0.0
350424361 1626 PREDICTED: CD109 antigen-like [Bombus im 0.676 0.296 0.743 0.0
328792914 1612 PREDICTED: CD109 antigen [Apis mellifera 0.676 0.299 0.737 0.0
322788458 1638 hypothetical protein SINV_07362 [Solenop 0.666 0.289 0.733 0.0
307189197 1638 CD109 antigen [Camponotus floridanus] 0.666 0.289 0.734 0.0
328720350 1635 PREDICTED: CD109 antigen-like [Acyrthosi 0.657 0.286 0.705 0.0
332017032 1633 CD109 antigen [Acromyrmex echinatior] 0.664 0.290 0.705 0.0
307204248 1629 CD109 antigen [Harpegnathos saltator] 0.663 0.290 0.703 0.0
>gi|340722713|ref|XP_003399747.1| PREDICTED: CD109 antigen [Bombus terrestris] Back     alignment and taxonomy information
 Score =  754 bits (1948), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/483 (74%), Positives = 411/483 (85%), Gaps = 1/483 (0%)

Query: 178  LYIWET-LMLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNIS 236
             Y WE  L +  +VI QAVSW+L +QTP+GSFYE TW+ DRK+NSSLN+ +D +  RNIS
Sbjct: 1132 FYEWENYLYIDPEVIAQAVSWLLKYQTPEGSFYEVTWMPDRKMNSSLNYDDDIITHRNIS 1191

Query: 237  LTAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLS 296
            LTAHVLITL +VKDL  GLG +V+++ + AIKWLERNL+LL+  G PYE+AIV+YAL L+
Sbjct: 1192 LTAHVLITLQSVKDLPEGLGTQVAVSAAGAIKWLERNLKLLEVRGKPYEIAIVSYALLLA 1251

Query: 297  KATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETT 356
            KA+ A  AF IL++HAR EGGLTYWG+E VP PP K+ENQKPFLLPRLPY YD+ NIETT
Sbjct: 1252 KASTAGQAFNILSRHARREGGLTYWGRESVPLPPYKLENQKPFLLPRLPYMYDSENIETT 1311

Query: 357  AYALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYL 416
            AYALLV+V+RQE++ +PIVKWLNSQRLTDGGWASTQDTA AMKAL++YT R R+RDVS L
Sbjct: 1312 AYALLVHVARQEIMLEPIVKWLNSQRLTDGGWASTQDTAWAMKALMDYTVRSRIRDVSSL 1371

Query: 417  TVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDI 476
             V++EATALPGQ K L V +NNLA+LQ IEIP+AWGTVKVQA GAGYAILQMSV YNVDI
Sbjct: 1372 AVTVEATALPGQTKTLFVNDNNLARLQTIEIPEAWGTVKVQAKGAGYAILQMSVQYNVDI 1431

Query: 477  AKFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYII 536
            AKFQTQPPV +F L TRANFHGRNQSHI+Y SCQRWI  NES+RSGMAVLDVAIPTGYII
Sbjct: 1432 AKFQTQPPVKSFDLVTRANFHGRNQSHISYLSCQRWINTNESSRSGMAVLDVAIPTGYII 1491

Query: 537  QQQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPI 596
            QQQ LD YI+++ V NLQRARF E+KVLFYFDYLD  ETC+NFTIERWFPVANMSRYLPI
Sbjct: 1492 QQQTLDRYIQSKQVRNLQRARFHEKKVLFYFDYLDQEETCVNFTIERWFPVANMSRYLPI 1551

Query: 597  RVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNLAVALSCPPVFFLSFFVL 656
            R+YDYYAPERFNETIFDALPTY LNICEVCGSSQCPYCPIYN A  L+ P  F L+  VL
Sbjct: 1552 RIYDYYAPERFNETIFDALPTYTLNICEVCGSSQCPYCPIYNTATMLATPTGFLLAISVL 1611

Query: 657  SVV 659
             VV
Sbjct: 1612 VVV 1614




Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383857206|ref|XP_003704096.1| PREDICTED: CD109 antigen-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|242012592|ref|XP_002427015.1| conserved hypothetical protein [Pediculus humanus corporis] gi|212511253|gb|EEB14277.1| conserved hypothetical protein [Pediculus humanus corporis] Back     alignment and taxonomy information
>gi|350424361|ref|XP_003493770.1| PREDICTED: CD109 antigen-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|328792914|ref|XP_397416.3| PREDICTED: CD109 antigen [Apis mellifera] Back     alignment and taxonomy information
>gi|322788458|gb|EFZ14127.1| hypothetical protein SINV_07362 [Solenopsis invicta] Back     alignment and taxonomy information
>gi|307189197|gb|EFN73645.1| CD109 antigen [Camponotus floridanus] Back     alignment and taxonomy information
>gi|328720350|ref|XP_001948864.2| PREDICTED: CD109 antigen-like [Acyrthosiphon pisum] Back     alignment and taxonomy information
>gi|332017032|gb|EGI57831.1| CD109 antigen [Acromyrmex echinatior] Back     alignment and taxonomy information
>gi|307204248|gb|EFN83045.1| CD109 antigen [Harpegnathos saltator] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query713
FB|FBgn02648001760 Mcr "Macroglobulin complement- 0.636 0.257 0.653 2.5e-215
UNIPROTKB|F1PM261445 CD109 "Uncharacterized protein 0.551 0.271 0.280 3e-37
UNIPROTKB|F1MPE11447 CD109 "Uncharacterized protein 0.563 0.277 0.270 3.6e-36
UNIPROTKB|F1NN851750 CPAMD8 "Uncharacterized protei 0.375 0.153 0.317 1.4e-35
UNIPROTKB|Q6YHK31445 CD109 "CD109 antigen" [Homo sa 0.551 0.271 0.261 3.1e-35
UNIPROTKB|K7GP251368 CD109 "Uncharacterized protein 0.551 0.287 0.273 3.7e-35
UNIPROTKB|K7GKY01449 CD109 "Uncharacterized protein 0.551 0.271 0.273 4.4e-35
UNIPROTKB|F1RQH91450 CD109 "Uncharacterized protein 0.551 0.271 0.272 4.4e-34
UNIPROTKB|E1BAA21792 CPAMD8 "Uncharacterized protei 0.495 0.196 0.333 8.9e-34
UNIPROTKB|F1S9U5 1869 CPAMD8 "Uncharacterized protei 0.527 0.201 0.323 8.9e-34
FB|FBgn0264800 Mcr "Macroglobulin complement-related" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 1624 (576.7 bits), Expect = 2.5e-215, Sum P(3) = 2.5e-215
 Identities = 302/462 (65%), Positives = 371/462 (80%)

Query:   179 YIWETLM-LPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISL 237
             Y WE  + +   +I + + W+L HQTP GSF+E TWL DRK+N +    N D   +NI+L
Sbjct:  1271 YEWENFIWIDATIIEKNMRWLLQHQTPQGSFFEVTWLPDRKMNRT----NFD---KNITL 1323

Query:   238 TAHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSK 297
             T+HVLITL TVKD++G LG+RV+LA  +A+ ++ERN+  L+    P++VAI AYAL+L  
Sbjct:  1324 TSHVLITLATVKDISGTLGSRVALATQRALAYIERNMDFLRHQAQPFDVAITAYALQLCN 1383

Query:   298 ATIAEAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTA 357
             + IAE  F IL + AR+ G   YWG + +P PP K+ENQK F LPRLPY+YD++NIETTA
Sbjct:  1384 SPIAEEVFAILRRQARTIGDFMYWGNQEIPQPPRKLENQKWFSLPRLPYEYDSLNIETTA 1443

Query:   358 YALLVYVSRQELLTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLT 417
             YALLVYV+R+E   DPIV+WLNSQRL DGGWASTQDT+ A+KAL+EYT R RLR+VS LT
Sbjct:  1444 YALLVYVARREFFVDPIVRWLNSQRLNDGGWASTQDTSAALKALVEYTVRSRLREVSSLT 1503

Query:   418 VSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIA 477
             V IEA++  G+ + L++ + NLA+LQ IEIP AWGT+KVQA GAGYAILQM V YNVDI 
Sbjct:  1504 VEIEASSQGGKTQTLYIDDTNLAKLQSIEIPDAWGTIKVQAKGAGYAILQMHVQYNVDIE 1563

Query:   478 KFQTQPPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQ 537
             KFQT+PPVPAF L+T+A FHGRNQSHI+Y +CQ WI QNES RSGMAVLDVAIPTGY IQ
Sbjct:  1564 KFQTKPPVPAFGLHTKAIFHGRNQSHISYVACQNWINQNESERSGMAVLDVAIPTGYWIQ 1623

Query:   538 QQKLDAYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIR 597
             QQKLD Y+ +  V NL+RAR+ E+K++FYFDYLD  + C+NFTIERW+PVANMSRYLP+R
Sbjct:  1624 QQKLDTYVLSNRVRNLRRARYLERKIVFYFDYLDHEDICVNFTIERWYPVANMSRYLPVR 1683

Query:   598 VYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPIYNL 639
             +YDYYAPERFNE+IFDALPTYLLNICEVCGSSQCPYC IYN+
Sbjct:  1684 IYDYYAPERFNESIFDALPTYLLNICEVCGSSQCPYCSIYNM 1725


GO:0004866 "endopeptidase inhibitor activity" evidence=ISS
GO:0019731 "antibacterial humoral response" evidence=IDA
GO:0005615 "extracellular space" evidence=IEA
GO:0001878 "response to yeast" evidence=IMP
GO:0043499 "eukaryotic cell surface binding" evidence=IDA
GO:0006911 "phagocytosis, engulfment" evidence=IMP
GO:0005515 "protein binding" evidence=IPI
GO:0046331 "lateral inhibition" evidence=IMP
UNIPROTKB|F1PM26 CD109 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1MPE1 CD109 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|F1NN85 CPAMD8 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|Q6YHK3 CD109 "CD109 antigen" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|K7GP25 CD109 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|K7GKY0 CD109 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|F1RQH9 CD109 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|E1BAA2 CPAMD8 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|F1S9U5 CPAMD8 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query713
pfam07678248 pfam07678, A2M_comp, A-macroglobulin complement co 5e-62
cd02896297 cd02896, complement_C3_C4_C5, Proteins similar to 1e-34
cd02897292 cd02897, A2M_2, Proteins similar to alpha2-macrogl 3e-33
cd02891282 cd02891, A2M_like, Proteins similar to alpha2-macr 5e-31
pfam0767790 pfam07677, A2M_recep, A-macroglobulin receptor 9e-25
cd00688300 cd00688, ISOPREN_C2_like, This group contains clas 7e-21
pfam07703136 pfam07703, A2M_N_2, Alpha-2-macroglobulin family N 1e-05
>gnl|CDD|219510 pfam07678, A2M_comp, A-macroglobulin complement component Back     alignment and domain information
 Score =  207 bits (529), Expect = 5e-62
 Identities = 81/221 (36%), Positives = 116/221 (52%), Gaps = 22/221 (9%)

Query: 186 LPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITL 245
           +  Q I Q+++W+L  Q PDGSF E   +  R++   +          +++LTA VLI L
Sbjct: 46  IDEQHICQSLNWLLSQQKPDGSFREPGPVFHREMKGGVE--------DDVTLTAFVLIAL 97

Query: 246 DTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLS-KATIAEAA 304
               D+     +RV  A  KA+++LE  +   +    PY +AI AYAL L+ K+  A   
Sbjct: 98  LEALDILPDELSRVDPAIDKALEYLESAV---EGLNRPYTLAITAYALTLAGKSPQASEL 154

Query: 305 FGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYV 364
              L   A+ EG   YW ++       K         P   Y   A  +ETTAYALL Y+
Sbjct: 155 LEKLKALAQEEGNSRYWERDEKSKDSGK---------PLYWYSAPAAEVETTAYALLAYL 205

Query: 365 SRQEL-LTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEY 404
           S  +L   DPIV+WL SQR + GG++STQDT +A++AL EY
Sbjct: 206 SLGDLTYADPIVRWLTSQRNSGGGFSSTQDTVVALQALSEY 246


This family includes the complement components region of the alpha-2-macroglobulin family. Length = 248

>gnl|CDD|239226 cd02896, complement_C3_C4_C5, Proteins similar to C3, C4 and C5 of vertebrate complement Back     alignment and domain information
>gnl|CDD|239227 cd02897, A2M_2, Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>gnl|CDD|239221 cd02891, A2M_like, Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>gnl|CDD|203720 pfam07677, A2M_recep, A-macroglobulin receptor Back     alignment and domain information
>gnl|CDD|238362 cd00688, ISOPREN_C2_like, This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement Back     alignment and domain information
>gnl|CDD|219528 pfam07703, A2M_N_2, Alpha-2-macroglobulin family N-terminal region Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 713
KOG1366|consensus1436 100.0
PF07678246 A2M_comp: A-macroglobulin complement component; In 100.0
cd02896297 complement_C3_C4_C5 Proteins similar to C3, C4 and 100.0
cd02897292 A2M_2 Proteins similar to alpha2-macroglobulin (al 100.0
cd02891282 A2M_like Proteins similar to alpha2-macroglobulin 99.95
PF0767791 A2M_recep: A-macroglobulin receptor; InterPro: IPR 99.91
COG23731621 Large extracellular alpha-helical protein [General 99.73
cd02889348 SQCY Squalene cyclase (SQCY) domain; found in clas 99.7
cd00688300 ISOPREN_C2_like This group contains class II terpe 99.6
cd02892634 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; 99.5
cd00688300 ISOPREN_C2_like This group contains class II terpe 99.02
TIGR01507635 hopene_cyclase squalene-hopene cyclase. SHC is an 98.9
TIGR03463634 osq_cycl 2,3-oxidosqualene cyclase. This model ide 98.89
TIGR01787621 squalene_cyclas squalene/oxidosqualene cyclases. T 98.82
cd02897292 A2M_2 Proteins similar to alpha2-macroglobulin (al 98.79
cd02889348 SQCY Squalene cyclase (SQCY) domain; found in clas 98.72
PLN03012759 Camelliol C synthase 98.67
cd02896297 complement_C3_C4_C5 Proteins similar to C3, C4 and 98.55
PLN02993763 lupeol synthase 98.52
cd02891282 A2M_like Proteins similar to alpha2-macroglobulin 98.43
PF13249113 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 98.22
cd02892634 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; 98.02
TIGR03463634 osq_cycl 2,3-oxidosqualene cyclase. This model ide 97.97
TIGR01507635 hopene_cyclase squalene-hopene cyclase. SHC is an 97.92
cd02890286 PTase Protein prenyltransferase (PTase) domain, be 97.77
TIGR01787621 squalene_cyclas squalene/oxidosqualene cyclases. T 97.58
cd02890286 PTase Protein prenyltransferase (PTase) domain, be 97.45
PF07678246 A2M_comp: A-macroglobulin complement component; In 97.33
cd02893299 FTase Protein farnesyltransferase (FTase)_like pro 97.25
cd02894287 GGTase-II Geranylgeranyltransferase type II (GGTas 97.2
COG1689274 Uncharacterized protein conserved in archaea [Func 97.17
cd02894287 GGTase-II Geranylgeranyltransferase type II (GGTas 97.1
PLN03012759 Camelliol C synthase 96.86
PLN03201316 RAB geranylgeranyl transferase beta-subunit; Provi 96.68
PLN02993763 lupeol synthase 96.65
PF13243109 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 96.52
PF13249113 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 96.2
cd02895307 GGTase-I Geranylgeranyltransferase types I (GGTase 96.03
PLN02710439 farnesyltranstransferase subunit beta 95.87
cd02893299 FTase Protein farnesyltransferase (FTase)_like pro 95.75
PLN03201316 RAB geranylgeranyl transferase beta-subunit; Provi 95.66
PF13243109 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 95.64
PF01122326 Cobalamin_bind: Eukaryotic cobalamin-binding prote 94.91
cd02895307 GGTase-I Geranylgeranyltransferase types I (GGTase 94.66
KOG0497|consensus760 94.14
KOG0365|consensus423 90.99
) (2,3-epoxysqualene-cycloartenol cyclase) is a plant enzyme that catalyzes the cyclization of (S)-2,3-epoxysqualene to cycloartenol.; GO: 0003824 catalytic activity; PDB: 2IEJ_B 1LD7_B 1LD8_B 2H6G_B 1TN6_B 1S63_B 1MZC_B 2H6I_B 2H6F_B 1JCQ_B ...." target="_blank" href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=PF00432">PF0043244 Prenyltrans: Prenyltransferase and squalene oxidas 90.71
COG5029342 CAL1 Prenyltransferase, beta subunit [Posttranslat 89.13
KOG0366|consensus329 84.62
) (2,3-epoxysqualene-cycloartenol cyclase) is a plant enzyme that catalyzes the cyclization of (S)-2,3-epoxysqualene to cycloartenol.; GO: 0003824 catalytic activity; PDB: 2IEJ_B 1LD7_B 1LD8_B 2H6G_B 1TN6_B 1S63_B 1MZC_B 2H6I_B 2H6F_B 1JCQ_B ...." target="_blank" href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=PF00432">PF0043244 Prenyltrans: Prenyltransferase and squalene oxidas 84.47
KOG0497|consensus760 83.5
>KOG1366|consensus Back     alignment and domain information
Probab=100.00  E-value=2.1e-79  Score=742.28  Aligned_cols=568  Identities=30%  Similarity=0.446  Sum_probs=462.3

Q ss_pred             cceeEeeeeeEEEE-----EEEEEEeeCCCEEEEeccCCCccce---eeEE--eeCCcccccccccEEEEEEEEecceee
Q psy742           16 GQENMQSTIRSFAV-----SLSAEMAPSATIVVYNVGRNGDVIA---DSLT--FPVNGISRNNVNATVVFLPIVPVHLGD   85 (713)
Q Consensus        16 ~~~~~~~~~~~f~~-----~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~V~F~I~p~~lG~   85 (713)
                      -||.+++++++|-.     .|+|+|.+++++|+......++...   .++.  +-.+..     +++.|+|+|+|..+|.
T Consensus       775 RgE~i~l~~tv~NYl~k~~~v~V~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~-----s~~~~~~~v~p~~~g~  849 (1436)
T KOG1366|consen  775 RGEQIALRVTVFNYLTKELDVSVILLSSEDFCYDATSKANEQVGVSQRSVQVSRVTPAQ-----SGKLVYFPVRPGVIGL  849 (1436)
T ss_pred             eCcEeEEeEEEecccCcceEEEEEEccCCCeeeecccccCcccccccceEEEEEEcccc-----cceEEEEEeccccccc
Confidence            48999999999954     9999999999999997433333322   1111  111111     3899999999999999


Q ss_pred             EEEEEEEEecCCCceEEEEEEEecCCeEEEEeEeeeeecccccceeeeeeeccCCCCccCCCCc-eEEEEecC-----CC
Q psy742           86 IDVTVTASSLIGRDTVTRKLHIIADGLPQHRHQSILLDLSNRAYVFQYLHVNVTETPIIPYDVD-RYYVYGSS-----IN  159 (713)
Q Consensus        86 i~I~V~A~s~~~sD~V~~~L~V~peGv~~~~~~s~~ld~~~~~~~~~~~~~~~p~~~~ip~s~~-~~~v~Gs~-----~~  159 (713)
                      ++++++|.+..+.|+|+|+|+|+|||++++++++.+||++.  ...+.+.+.+|.+ .+|+++. ++.+.|+.     +|
T Consensus       850 ~~~~~~~~t~~~~dav~k~l~V~~eG~~~~~~~~~~i~l~~--~~~~~~~~~~p~~-~V~~S~~~~~~~vgD~lGps~~~  926 (1436)
T KOG1366|consen  850 ILVTISALTLLGGDAVHKTLLVEPEGITQERNFSVLIDLSV--SASKELSLGVPND-VVPGSERARISVVGDVLGPSMNN  926 (1436)
T ss_pred             cceEEEEeecCCCccEEEEEEEeccCccceeeeeEEeccCC--CcCcceeecCCCC-cCccccceeeEEEecccccChhh
Confidence            99999999999999999999999999999999999999983  3456667777775 7899854 77888776     88


Q ss_pred             ccccccccch-----------------------------------------------------------------hhhhh
Q psy742          160 SSSISTLKML-----------------------------------------------------------------LWYSC  174 (713)
Q Consensus       160 l~sLi~~P~g-----------------------------------------------------------------tWL~T  174 (713)
                      +++|++||||                                                                 ||| |
T Consensus       927 l~~Ll~lP~GcGEQnMi~faPni~v~~YL~~t~q~~~~~k~ka~~~l~~GyqrqL~yk~~DgSySaFg~~~~~~stWL-t 1005 (1436)
T KOG1366|consen  927 LSNLLRLPYGCGEQNMINFAPNIYVLKYLPKTNQLTPELKRKALKFLEQGYQRQLTYKRADGSYSAFGSSDRSGSTWL-T 1005 (1436)
T ss_pred             hHHhccCCCCcccceeecccchhhHHHHHhhhhccChhHHHHHHHHHHHHHHHHHhhhccCCChhhhcCCCCcccHHH-H
Confidence            9999999998                                                                 999 9


Q ss_pred             hHH---hhhhhcc-CCCHHHHHHHHHHHHhccCCCcceeeccccccccccccCCCCCCCcccCcceehHHHHHHHHhccc
Q psy742          175 LLC---LYIWETL-MLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTVKD  250 (713)
Q Consensus       175 AfV---F~qa~~~-~ID~~~I~~ai~WL~~~Q~~dG~F~e~g~v~h~~m~g~~~Gg~~~~~~~~v~LTAyVliaL~ea~~  250 (713)
                      |||   |.+|++| +||+++|++++.||.++|++||+|.+.|+++|++|||++++        .+.|||+++..+.+.. 
T Consensus      1006 afvlr~f~~a~~~i~id~~~i~~a~~wl~~~Qk~~GsF~e~~~v~~~~~qg~l~~--------~~~l~~~~l~~~~~~~- 1076 (1436)
T KOG1366|consen 1006 AFVLRVFSQAKEYIFIDPNVITQALNWLSQQQKENGSFKEVGEVLHNEMQGGLQD--------IVALTAIVLSVILDVD- 1076 (1436)
T ss_pred             HHHHHHhhhccCceEecHHHHHHHHHHHHHhhccCceEeccccccchhhhcCCCC--------cceeeeEeeeeeccch-
Confidence            999   9999999 99999999999999999999999999999999999987653        2789999999885432 


Q ss_pred             ccCCCCCchhHHHHHHHHHHHHhhhhccCCCChHHHHHHHHHHHhcCCccHHHHHHHHHHhhhccCCceeecCCC-CCCC
Q psy742          251 LTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGLTYWGKEP-VPAP  329 (713)
Q Consensus       251 l~~g~~~~~~~~~~kA~~yLe~~~~~~~~~~~~YtlAl~aYALaLa~~~~~~~al~~L~~~a~~~~~~~~W~~~~-~~~~  329 (713)
                               .....+|..|++++++...  .++|+.|+++|||.++++|.+..++..|+..++.+++..||.... .+.+
T Consensus      1077 ---------~~~~~~a~~~~~~~~~~~~--~~~~~~a~~ayAl~l~~sp~a~~~~~~l~~~a~~~~d~~~~~~~~~~~~~ 1145 (1436)
T KOG1366|consen 1077 ---------NASIQKAVAYLEESLDSGS--MDVYTVAITAYALQLAKSPQAAKALAKLKSLARVEGDRRYWWASALKAKN 1145 (1436)
T ss_pred             ---------hhHHHHHHHHHhhccCccc--cccchHHHHHHHHHhccCchHHHHHHhhhhhhcccCCceeeeeccccccC
Confidence                     2467999999999998752  399999999999999999999888888999999888766554432 2111


Q ss_pred             CCCccCCCCCCCCCCCCCCCcchhhHHHHHHHHHhhcCCc-chhHHHHHHHhcccCCCCccchhhHHHHHHHHHHHHHhc
Q psy742          330 PSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQEL-LTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRH  408 (713)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~s~~VEtTAYALLa~l~~~~~-~a~~Iv~WL~~Qrn~~GGF~STQDTvvALqALa~Ya~~~  408 (713)
                      +.     .  |    +...++.+||+||||||+++.+++. .+.||+|||++|||..|||+|||||++|||||++|+...
T Consensus      1146 ~~-----~--~----~~q~~s~~VE~tsYaLL~~~~~~~~~~~~pivrWl~~qr~~~GGf~STQdTvvalqaLs~y~~~~ 1214 (1436)
T KOG1366|consen 1146 AV-----K--Y----SPQARSIDVETTAYALLAYLLLAQVDYALPIVRWLVEQRNALGGFSSTQDTVVALQALSEYAALS 1214 (1436)
T ss_pred             cc-----c--C----CCccchhhccchHHHHHHHHHhcccCcCchhHhhhhhhhcccCceeehHHHHHHHHHHHHhhhhc
Confidence            11     0  1    1123689999999999999999988 999999999999999999999999999999999999988


Q ss_pred             ccCCcceeEEEEEEecCCCceeEEEEeccCcceeEeEEecCCCceEEEEEEeeeEEEEEEEEEEeeccccccCCCCCCCe
Q psy742          409 RLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQPPVPAF  488 (713)
Q Consensus       409 ~~~~~~~l~v~V~~~~~~~~~~~~~I~~~N~~~~q~~~lp~~~g~v~v~a~G~G~a~~q~~~~Yn~~~~~~~~~~~~~~F  488 (713)
                      +... ..++|++...+......++.+...|.+++|+.++|..++.+.++++|.||+++|+.++||+..++     +++.|
T Consensus      1215 ~~~~-~~~~V~i~~~~~~~~~~~~~~~~~N~lllQ~~~~p~~~~~v~~ta~G~g~~~~q~~~~Ynv~~~~-----~~~~f 1288 (1436)
T KOG1366|consen 1215 HTET-LSLQVTIQVPGKSSGTSQVDSTPNNLLLLQSVSLPSLHKTVCFTAKGQGCATVQISYTYNLLTPK-----SDPRF 1288 (1436)
T ss_pred             ccce-eEEEEEEEecccCCCceeeeccccchhhcceeecccCCCceEEEEecceeEEEEeeEEEeecCcc-----cCCCc
Confidence            7533 34567776644333334455558899999999999999999999999999999999999998753     56789


Q ss_pred             eEEEEeec--cCCCCceeEEEEEEEeeccCCCCccceEEEEEecCcceeecccchHHHhccCCCCcceeE--EEeCCEEE
Q psy742          489 ALNTRANF--HGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNLQRA--RFQEQKVL  564 (713)
Q Consensus       489 ~L~v~~~~--~~~~~~~~~l~vC~~~~~~~~~~~s~MaiveV~lpSGf~~~~~~L~~l~~~~~~~~i~~~--E~~d~~V~  564 (713)
                      .|.+....  ...+..+..+..|..+...+.++.|||||+||+|||||.++.++|..+....   .+.+.  +..+.+|+
T Consensus      1289 ~l~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~SnMAIldVklpSGf~~~~~sl~~le~~~---~v~~~~~~~~~~~v~ 1365 (1436)
T KOG1366|consen 1289 FLIVSTKPEPVEFDLSNIVVVYTTCCERTGSSGRSNMAILDVKLPSGFRADHESLGLLEQLE---DVYRVEVENDHRRVL 1365 (1436)
T ss_pred             eeeeeeccccccCccccceEEEEEEEeecCCCCCCCceeeeeecccCcccChhhHHHhhccc---eEEEEEEecCCcceE
Confidence            99887632  2233344433333333344556899999999999999999999999986532   34444  44555699


Q ss_pred             EEEecCC-CceeEEEEEEEEEeeeeccccceeEEEEeccCCCceeEEEeecCcccccccccccCCCCCCCCCC
Q psy742          565 FYFDYLD-DTETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALPTYLLNICEVCGSSQCPYCPI  636 (713)
Q Consensus       565 lYfd~l~-~~~~cv~f~~~~~~~V~~~~~pa~v~VYDYY~P~~~~~~~y~~~~~~~~~~C~~C~~~~C~~c~~  636 (713)
                      +|||+++ ++..|+.|++.++++|+++ +||+++|||||+||++|+.+|+....+   +|++|.+.+|+.|..
T Consensus      1366 ~Y~D~v~~~~~~cv~F~a~~~~~V~~~-kpa~v~VYDYY~pee~~t~~Y~~~~~~---~~~~c~~~~c~~~c~ 1434 (1436)
T KOG1366|consen 1366 IYFDSVSGNETFCVRFEAVQSFPVANL-KPASVTVYDYYEPEEQATRFYNAESSS---SCDVCEGAQCKCPCE 1434 (1436)
T ss_pred             EEeeccCCCCceEEEEEEEEEeehhcc-CCceEEEeeccCchhhhhhhhcccccc---hhhhcccccCCcCCC
Confidence            9999999 6999999999999999999 699999999999999988888764322   888888889986654



>PF07678 A2M_comp: A-macroglobulin complement component; InterPro: IPR011626 This domain covers the complement component region of the alpha-2-macroglobulin family Back     alignment and domain information
>cd02896 complement_C3_C4_C5 Proteins similar to C3, C4 and C5 of vertebrate complement Back     alignment and domain information
>cd02897 A2M_2 Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>cd02891 A2M_like Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>PF07677 A2M_recep: A-macroglobulin receptor; InterPro: IPR009048 This entry represents the receptor-binding domain (RBD) of alpha-2-macroglobulin proteins Back     alignment and domain information
>COG2373 Large extracellular alpha-helical protein [General function prediction only] Back     alignment and domain information
>cd02889 SQCY Squalene cyclase (SQCY) domain; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold Back     alignment and domain information
>cd00688 ISOPREN_C2_like This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement Back     alignment and domain information
>cd02892 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold Back     alignment and domain information
>cd00688 ISOPREN_C2_like This group contains class II terpene cyclases, protein prenyltransferases beta subunit, two broadly specific proteinase inhibitors alpha2-macroglobulin (alpha (2)-M) and pregnancy zone protein (PZP) and, the C3 C4 and C5 components of vertebrate complement Back     alignment and domain information
>TIGR01507 hopene_cyclase squalene-hopene cyclase Back     alignment and domain information
>TIGR03463 osq_cycl 2,3-oxidosqualene cyclase Back     alignment and domain information
>TIGR01787 squalene_cyclas squalene/oxidosqualene cyclases Back     alignment and domain information
>cd02897 A2M_2 Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>cd02889 SQCY Squalene cyclase (SQCY) domain; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold Back     alignment and domain information
>PLN03012 Camelliol C synthase Back     alignment and domain information
>cd02896 complement_C3_C4_C5 Proteins similar to C3, C4 and C5 of vertebrate complement Back     alignment and domain information
>PLN02993 lupeol synthase Back     alignment and domain information
>cd02891 A2M_like Proteins similar to alpha2-macroglobulin (alpha (2)-M) Back     alignment and domain information
>PF13249 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 1O6Q_B 1H35_C 1H3A_C 1SQC_A 1UMP_A 1O6H_C 1O79_B 1GSZ_C 1H37_C Back     alignment and domain information
>cd02892 SQCY_1 Squalene cyclase (SQCY) domain subgroup 1; found in class II terpene cyclases that have an alpha 6 - alpha 6 barrel fold Back     alignment and domain information
>TIGR03463 osq_cycl 2,3-oxidosqualene cyclase Back     alignment and domain information
>TIGR01507 hopene_cyclase squalene-hopene cyclase Back     alignment and domain information
>cd02890 PTase Protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>TIGR01787 squalene_cyclas squalene/oxidosqualene cyclases Back     alignment and domain information
>cd02890 PTase Protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>PF07678 A2M_comp: A-macroglobulin complement component; InterPro: IPR011626 This domain covers the complement component region of the alpha-2-macroglobulin family Back     alignment and domain information
>cd02893 FTase Protein farnesyltransferase (FTase)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>cd02894 GGTase-II Geranylgeranyltransferase type II (GGTase-II)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>COG1689 Uncharacterized protein conserved in archaea [Function unknown] Back     alignment and domain information
>cd02894 GGTase-II Geranylgeranyltransferase type II (GGTase-II)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>PLN03012 Camelliol C synthase Back     alignment and domain information
>PLN03201 RAB geranylgeranyl transferase beta-subunit; Provisional Back     alignment and domain information
>PLN02993 lupeol synthase Back     alignment and domain information
>PF13243 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 3SAE_A 3SDV_A 3SDT_A 3SDQ_A 3SDU_A Back     alignment and domain information
>PF13249 Prenyltrans_2: Prenyltransferase-like; PDB: 1O6R_B 1O6Q_B 1H35_C 1H3A_C 1SQC_A 1UMP_A 1O6H_C 1O79_B 1GSZ_C 1H37_C Back     alignment and domain information
>cd02895 GGTase-I Geranylgeranyltransferase types I (GGTase-I)-like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>PLN02710 farnesyltranstransferase subunit beta Back     alignment and domain information
>cd02893 FTase Protein farnesyltransferase (FTase)_like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>PLN03201 RAB geranylgeranyl transferase beta-subunit; Provisional Back     alignment and domain information
>PF13243 Prenyltrans_1: Prenyltransferase-like; PDB: 3SDR_A 3SAE_A 3SDV_A 3SDT_A 3SDQ_A 3SDU_A Back     alignment and domain information
>PF01122 Cobalamin_bind: Eukaryotic cobalamin-binding protein; InterPro: IPR002157 Cobalamin (Cbl or vitamin B12) is only accessible through diet in mammals Back     alignment and domain information
>cd02895 GGTase-I Geranylgeranyltransferase types I (GGTase-I)-like proteins containing the protein prenyltransferase (PTase) domain, beta subunit (alpha 6 - alpha 6 barrel fold) Back     alignment and domain information
>KOG0497|consensus Back     alignment and domain information
>KOG0365|consensus Back     alignment and domain information
>PF00432 Prenyltrans: Prenyltransferase and squalene oxidase repeat This Prosite family is a subset of the Pfam family Back     alignment and domain information
>COG5029 CAL1 Prenyltransferase, beta subunit [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0366|consensus Back     alignment and domain information
>PF00432 Prenyltrans: Prenyltransferase and squalene oxidase repeat This Prosite family is a subset of the Pfam family Back     alignment and domain information
>KOG0497|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query713
4d93_A1323 Crystal Structure Of Tep1s Length = 1323 5e-28
2pn5_A1325 Crystal Structure Of Tep1r Length = 1325 3e-27
4d94_A1325 Crystal Structure Of Tep1r Length = 1325 3e-27
4acq_A1451 Alpha-2 Macroglobulin Length = 1451 3e-21
2i07_B915 Human Complement Component C3b Length = 915 5e-18
2a73_B991 Human Complement Component C3 Length = 991 5e-18
2hr0_B915 Structure Of Complement C3b: Insights Into Compleme 5e-18
2xwb_B912 Crystal Structure Of Complement C3b In Complex With 5e-18
2b39_A1661 Structure Of Mammalian C3 With An Intact Thioester 9e-18
3oxu_A317 Complement Components Factor H Ccp19-20 And C3d In 1e-13
2wy7_A310 Staphylococcus Aureus Complement Subversion Protein 1e-13
1ghq_A308 Cr2-C3d Complex Structure Length = 308 2e-13
1c3d_A294 X-ray Crystal Structure Of C3d: A C3 Fragment And L 2e-13
1w2s_A307 Solution Structure Of Cr2 Scr 1-2 In Its Complex Wi 2e-13
2gox_A297 Crystal Structure Of Efb-c / C3d Complex Length = 2 2e-13
3prx_B1642 Structure Of Complement C5 In Complex With Cvf And 3e-12
1qsj_A277 N-Terminally Truncated C3dg Fragment Length = 277 4e-12
1qqf_A277 N-Terminally Truncated C3d,G Fragment Of The Comple 5e-12
4fxk_B767 Human Complement C4 Length = 767 1e-09
4fxg_B767 Complement C4 In Complex With Masp-2 Length = 767 1e-09
4a5w_A1580 Crystal Structure Of C5b6 Length = 1580 8e-09
3prx_A1676 Structure Of Complement C5 In Complex With Cvf And 9e-09
3cu7_A1676 Human Complement Component 5 Length = 1676 9e-09
1hzf_A367 C4adg Fragment Of Human Complement Factor C4a Lengt 3e-07
1edy_A134 Crystal Structure Of Rat Alpha 1-Macroglobulin Rece 2e-06
1ayo_A130 Receptor Binding Domain Of Bovine Alpha-2-Macroglob 2e-04
1bv8_A138 Receptor Domain From Alpha-2-Macroglobulin Length = 3e-04
4fxg_C291 Complement C4 In Complex With Masp-2 Length = 291 8e-04
>pdb|4D93|A Chain A, Crystal Structure Of Tep1s Length = 1323 Back     alignment and structure

Iteration: 1

Score = 122 bits (307), Expect = 5e-28, Method: Compositional matrix adjust. Identities = 107/453 (23%), Positives = 199/453 (43%), Gaps = 73/453 (16%) Query: 190 VITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRN-ISLTAHVLITL--- 245 ++ +A+ W+ Q G F ET + + + L RN ++LT++VL L Sbjct: 925 MVEKALDWLASKQHSSGRFDETGKVWHKDMQGGL---------RNGVALTSYVLTALLEN 975 Query: 246 DTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAF 305 D K + ++ + +L L + +PY+++I YA+ L+ T+ + A Sbjct: 976 DIAK-------VKHAVVIQNGMNYLSNQLAFI---NNPYDLSIATYAMMLNGHTMKKEAL 1025 Query: 306 GILTQHARSEGGLT--YWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVY 363 L + S+ YWG NQ IETTAYALL + Sbjct: 1026 DKLIDMSISDNNKKERYWG----------TTNQ----------------IETTAYALLSF 1059 Query: 364 VSRQELLTD-PIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEA 422 V ++ L P++ WL +QR G + TQDT + +KAL + + Y TV ++ Sbjct: 1060 VMAEKYLDGIPVMNWLVNQRYVTGSFPRTQDTFVGLKALTKLAEKISPSRNDY-TVQLKY 1118 Query: 423 TALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQ 482 KY ++ + + +EIP+ +++ G G+ +L++ +++++ F+ + Sbjct: 1119 KK---NTKYFNINSEQIDVQNFLEIPEDTKKLEINVGGIGFGLLEVIYQFDLNLVNFEHR 1175 Query: 483 PPVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLD 542 + NT +++ R C +I + ++S MA+++V +P+GY++ + + Sbjct: 1176 FKLDLEKQNTGSDYELR------LRVCANYIPELTDSQSNMALIEVTLPSGYVVDRNPIS 1229 Query: 543 AYIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYY 602 + N++ R+ V+ Y+ + C T R F VA + R + VYDYY Sbjct: 1230 EQTTVNPIQNME-IRYGGTSVVLYYYKMGTERNCFTVTAYRRFKVA-LKRPAYVVVYDYY 1287 Query: 603 APERFNETIFDALPTYLL---NICEVCGSSQCP 632 T +A+ Y + N+CE+C CP Sbjct: 1288 ------NTNLNAIKVYEVDKQNVCEICEEEDCP 1314
>pdb|2PN5|A Chain A, Crystal Structure Of Tep1r Length = 1325 Back     alignment and structure
>pdb|4D94|A Chain A, Crystal Structure Of Tep1r Length = 1325 Back     alignment and structure
>pdb|4ACQ|A Chain A, Alpha-2 Macroglobulin Length = 1451 Back     alignment and structure
>pdb|2I07|B Chain B, Human Complement Component C3b Length = 915 Back     alignment and structure
>pdb|2A73|B Chain B, Human Complement Component C3 Length = 991 Back     alignment and structure
>pdb|2HR0|B Chain B, Structure Of Complement C3b: Insights Into Complement Activation And Regulation Length = 915 Back     alignment and structure
>pdb|2XWB|B Chain B, Crystal Structure Of Complement C3b In Complex With Factors B And D Length = 912 Back     alignment and structure
>pdb|2B39|A Chain A, Structure Of Mammalian C3 With An Intact Thioester At 3a Resolution Length = 1661 Back     alignment and structure
>pdb|3OXU|A Chain A, Complement Components Factor H Ccp19-20 And C3d In Complex Length = 317 Back     alignment and structure
>pdb|2WY7|A Chain A, Staphylococcus Aureus Complement Subversion Protein Sbi-Iv In Complex With Complement Fragment C3d Revealing An Alternative Binding Mode Length = 310 Back     alignment and structure
>pdb|1GHQ|A Chain A, Cr2-C3d Complex Structure Length = 308 Back     alignment and structure
>pdb|1C3D|A Chain A, X-ray Crystal Structure Of C3d: A C3 Fragment And Ligand For Complement Receptor 2 Length = 294 Back     alignment and structure
>pdb|1W2S|A Chain A, Solution Structure Of Cr2 Scr 1-2 In Its Complex With C3d By X-Ray Scattering Length = 307 Back     alignment and structure
>pdb|2GOX|A Chain A, Crystal Structure Of Efb-c / C3d Complex Length = 297 Back     alignment and structure
>pdb|3PRX|B Chain B, Structure Of Complement C5 In Complex With Cvf And Ssl7 Length = 1642 Back     alignment and structure
>pdb|1QSJ|A Chain A, N-Terminally Truncated C3dg Fragment Length = 277 Back     alignment and structure
>pdb|1QQF|A Chain A, N-Terminally Truncated C3d,G Fragment Of The Complement System Length = 277 Back     alignment and structure
>pdb|4FXK|B Chain B, Human Complement C4 Length = 767 Back     alignment and structure
>pdb|4FXG|B Chain B, Complement C4 In Complex With Masp-2 Length = 767 Back     alignment and structure
>pdb|4A5W|A Chain A, Crystal Structure Of C5b6 Length = 1580 Back     alignment and structure
>pdb|3PRX|A Chain A, Structure Of Complement C5 In Complex With Cvf And Ssl7 Length = 1676 Back     alignment and structure
>pdb|3CU7|A Chain A, Human Complement Component 5 Length = 1676 Back     alignment and structure
>pdb|1HZF|A Chain A, C4adg Fragment Of Human Complement Factor C4a Length = 367 Back     alignment and structure
>pdb|1EDY|A Chain A, Crystal Structure Of Rat Alpha 1-Macroglobulin Receptor Binding Domain Length = 134 Back     alignment and structure
>pdb|1AYO|A Chain A, Receptor Binding Domain Of Bovine Alpha-2-Macroglobulin Length = 130 Back     alignment and structure
>pdb|1BV8|A Chain A, Receptor Domain From Alpha-2-Macroglobulin Length = 138 Back     alignment and structure
>pdb|4FXG|C Chain C, Complement C4 In Complex With Masp-2 Length = 291 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query713
2pn5_A1325 TEP1R, thioester-containing protein I; FULL-length 2e-72
4acq_A1451 Alpha-2-macroglobulin; hydrolase inhibitor, protei 8e-69
4acq_A 1451 Alpha-2-macroglobulin; hydrolase inhibitor, protei 2e-07
3cu7_A1676 Complement C5; Mg domain, inflammation, anaphylato 1e-65
3cu7_A 1676 Complement C5; Mg domain, inflammation, anaphylato 4e-09
2hr0_B915 Complement C3 alpha' chain; complement component C 1e-61
2b39_A1661 C3; thioester, immune defense, immune system; HET: 2e-59
2b39_A 1661 C3; thioester, immune defense, immune system; HET: 8e-04
3prx_B1642 Cobra venom factor; immune system, complement, imm 1e-58
3prx_B 1642 Cobra venom factor; immune system, complement, imm 5e-04
1hzf_A367 Complement factor C4A; alpha-alpha 6 barrel, immun 5e-40
1qqf_A277 Protein (complement C3DG); alpha-alpha barrel, imm 9e-36
2wy7_A310 Complement C3D fragment; immune system, immune res 9e-33
3hrz_C379 Cobra venom factor; serine protease, glycosilated, 1e-32
1edy_A134 Alpha 1-macroglobulin; beta sandwich, pseudo-symme 4e-28
1ayo_A130 Alpha-2-macroglobulin; receptor binding domain; HE 2e-25
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-08
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-05
3hrz_B252 Cobra venom factor; serine protease, glycosilated, 3e-06
2sqc_A631 Squalene-hopene cyclase; isomerase, triterpene cyc 3e-05
3hrz_A627 Cobra venom factor; serine protease, glycosilated, 3e-04
1w6k_A732 Lanosterol synthase; cyclase, cholesterol, monotop 8e-04
>2pn5_A TEP1R, thioester-containing protein I; FULL-length mature peptide, immune system; HET: NAG; 2.70A {Anopheles gambiae} Length = 1325 Back     alignment and structure
 Score =  255 bits (651), Expect = 2e-72
 Identities = 95/456 (20%), Positives = 183/456 (40%), Gaps = 56/456 (12%)

Query: 185  MLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLIT 244
             +   ++ +A+ W+   Q   G F +      +++   L           ++LT++VL+ 
Sbjct: 920  DIDAAMVEKALDWLASKQHFSGRFDKAGAEYHKEMQGGLRN--------GVALTSYVLMA 971

Query: 245  LDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAA 304
            L           A+ +    K + +L      + +    Y+++I  YA+ L+  T+ E A
Sbjct: 972  LL----ENDIAKAKHAEVIQKGMTYLSNQFGSINN---AYDLSIATYAMMLNGHTMKEEA 1024

Query: 305  FGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYV 364
               L   +  +                              +      IETTAYALL +V
Sbjct: 1025 LNKLIDMSFIDADKNER------------------------FWNTTNPIETTAYALLSFV 1060

Query: 365  SRQEL-LTDPIVKWLNSQRLTDGGWASTQDTAMAMKALIEYTNRHRLRDVSYLTVSIEAT 423
              ++     P++ WL +QR   G + STQDT + +KAL +   +         TV ++  
Sbjct: 1061 MAEKYTDGIPVMNWLVNQRYVTGSFPSTQDTFVGLKALTKMAEKISPSRND-YTVQLKY- 1118

Query: 424  ALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIAKFQTQP 483
                  KY  + +  +     ++IP+    +++   G G+ +L++   +N+++  F+   
Sbjct: 1119 --KKSAKYFKINSEQIDVENFVDIPEDTKKLEINVGGIGFGLLEVVYQFNLNLVNFE--- 1173

Query: 484  PVPAFALNTRANFHGRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDA 543
                F L+      G +   +    C  +I Q    RS MA+++V +P+GY++ +  +  
Sbjct: 1174 --NRFQLDLEKQNTGSDY-ELRLKVCASYIPQLTDRRSNMALIEVTLPSGYVVDRNPISE 1230

Query: 544  YIRTRNVPNLQRARFQEQKVLFYFDYLDDTETCINFTIERWFPVANMSRYLPIRVYDYYA 603
              +   +      R+    V+ Y+D +     C   T  R F VA   R   + VYDYY 
Sbjct: 1231 QTKVNPI-QKTEIRYGGTSVVLYYDNMGSERNCFTLTAYRRFKVALK-RPAYVVVYDYYN 1288

Query: 604  PERFNETIFDALPTYLLNICEVCGSSQCP-YCPIYN 638
                   +++       N+CE+C    CP  C  ++
Sbjct: 1289 TNLNAIKVYEVDKQ---NLCEICDEEDCPAECGGHH 1321


>4acq_A Alpha-2-macroglobulin; hydrolase inhibitor, proteinase inhibitor, irreversible PROT inhibitor, conformational change, blood plasma inhibitor; HET: MEQ NAG MAN; 4.30A {Homo sapiens} Length = 1451 Back     alignment and structure
>4acq_A Alpha-2-macroglobulin; hydrolase inhibitor, proteinase inhibitor, irreversible PROT inhibitor, conformational change, blood plasma inhibitor; HET: MEQ NAG MAN; 4.30A {Homo sapiens} Length = 1451 Back     alignment and structure
>3cu7_A Complement C5; Mg domain, inflammation, anaphylatoxin, cleavage of basic residues, complement alternate pathway, glycoprotein, immune response; HET: NAG; 3.10A {Homo sapiens} PDB: 3kls_A* 3km9_A* 4e0s_A* 3prx_A* 3pvm_A* 4a5w_A* 1xwe_A Length = 1676 Back     alignment and structure
>3cu7_A Complement C5; Mg domain, inflammation, anaphylatoxin, cleavage of basic residues, complement alternate pathway, glycoprotein, immune response; HET: NAG; 3.10A {Homo sapiens} PDB: 3kls_A* 3km9_A* 4e0s_A* 3prx_A* 3pvm_A* 4a5w_A* 1xwe_A Length = 1676 Back     alignment and structure
>2hr0_B Complement C3 alpha' chain; complement component C3B, immune system; HET: THC; 2.26A {Homo sapiens} PDB: 2icf_B* 2wii_B* 2win_B* 3g6j_B 3l5n_B* 2a73_B* 2i07_B* 2xwj_B* 2xwb_B* 2a74_C* 2ice_C* 2qki_C* 3l3o_F* 3nms_C* 3nsa_C* 3ohx_C* 3t4a_C 2ice_B* 3l3o_B* 3nms_B* ... Length = 915 Back     alignment and structure
>2b39_A C3; thioester, immune defense, immune system; HET: NAG BMA; 3.00A {Bos taurus} Length = 1661 Back     alignment and structure
>2b39_A C3; thioester, immune defense, immune system; HET: NAG BMA; 3.00A {Bos taurus} Length = 1661 Back     alignment and structure
>3prx_B Cobra venom factor; immune system, complement, immune SYS complex; HET: NAG; 4.30A {Naja kaouthia} PDB: 3pvm_B* Length = 1642 Back     alignment and structure
>3prx_B Cobra venom factor; immune system, complement, immune SYS complex; HET: NAG; 4.30A {Naja kaouthia} PDB: 3pvm_B* Length = 1642 Back     alignment and structure
>1hzf_A Complement factor C4A; alpha-alpha 6 barrel, immune system; 2.30A {Homo sapiens} SCOP: a.102.4.4 Length = 367 Back     alignment and structure
>1qqf_A Protein (complement C3DG); alpha-alpha barrel, immune system; 1.45A {Rattus norvegicus} SCOP: a.102.4.4 PDB: 1qsj_A 3d5r_A 2noj_A 2gox_A 3d5s_A 1c3d_A 2xqw_A Length = 277 Back     alignment and structure
>2wy7_A Complement C3D fragment; immune system, immune response, innate immunity, complement inflammatory response; 1.70A {Homo sapiens} PDB: 2wy8_A 3oed_A 3oxu_A 3rj3_A 1ghq_A* 1w2s_A Length = 310 Back     alignment and structure
>3hrz_C Cobra venom factor; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Naja kaouthia} PDB: 3frp_B* 3hs0_C* Length = 379 Back     alignment and structure
>1edy_A Alpha 1-macroglobulin; beta sandwich, pseudo-symmetric dimer, protein binding; 2.30A {Rattus norvegicus} SCOP: b.2.4.1 Length = 134 Back     alignment and structure
>1ayo_A Alpha-2-macroglobulin; receptor binding domain; HET: NAG; 1.90A {Bos taurus} SCOP: b.2.4.1 PDB: 1bv8_A Length = 130 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3hrz_B Cobra venom factor; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Naja kaouthia} PDB: 3frp_G* 3hs0_B* Length = 252 Back     alignment and structure
>2sqc_A Squalene-hopene cyclase; isomerase, triterpene cyclase, monotopic membrane protein, QW-sequence, repeat; HET: C8E; 2.00A {Alicyclobacillus acidocaldarius} SCOP: a.102.4.2 a.102.4.2 PDB: 3sqc_A 1ump_A* 1h35_A* 1h36_A* 1h37_A* 1h39_A* 1h3a_A* 1h3b_A* 1h3c_A* 1o6h_A* 1o6q_A* 1gsz_A* 1o79_A* 1sqc_A* 1o6r_A* Length = 631 Back     alignment and structure
>3hrz_A Cobra venom factor; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Naja kaouthia} PDB: 3frp_A* 3hs0_A* Length = 627 Back     alignment and structure
>1w6k_A Lanosterol synthase; cyclase, cholesterol, monotopic membrane protein, B-octyl-glucoside, isomerase, steroid biosynthesis; HET: BOG LAN; 2.1A {Homo sapiens} SCOP: a.102.4.2 a.102.4.2 PDB: 1w6j_A* Length = 732 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query713
3prx_B1642 Cobra venom factor; immune system, complement, imm 100.0
4acq_A1451 Alpha-2-macroglobulin; hydrolase inhibitor, protei 100.0
2b39_A1661 C3; thioester, immune defense, immune system; HET: 100.0
3cu7_A1676 Complement C5; Mg domain, inflammation, anaphylato 100.0
2hr0_B915 Complement C3 alpha' chain; complement component C 100.0
2pn5_A1325 TEP1R, thioester-containing protein I; FULL-length 100.0
4fxk_B767 Complement C4-A alpha chain; immune system, proteo 100.0
1hzf_A367 Complement factor C4A; alpha-alpha 6 barrel, immun 100.0
2wy7_A310 Complement C3D fragment; immune system, immune res 100.0
3hrz_C379 Cobra venom factor; serine protease, glycosilated, 100.0
1qqf_A277 Protein (complement C3DG); alpha-alpha barrel, imm 100.0
1edy_A134 Alpha 1-macroglobulin; beta sandwich, pseudo-symme 99.96
1ayo_A130 Alpha-2-macroglobulin; receptor binding domain; HE 99.96
4fxk_C291 Complement C4 gamma chain; immune system, proteoly 99.95
2sqc_A631 Squalene-hopene cyclase; isomerase, triterpene cyc 99.66
1w6k_A732 Lanosterol synthase; cyclase, cholesterol, monotop 99.59
3hrz_B252 Cobra venom factor; serine protease, glycosilated, 99.52
2wy7_A310 Complement C3D fragment; immune system, immune res 98.44
1qqf_A277 Protein (complement C3DG); alpha-alpha barrel, imm 98.38
1w6k_A732 Lanosterol synthase; cyclase, cholesterol, monotop 98.3
2sqc_A631 Squalene-hopene cyclase; isomerase, triterpene cyc 98.27
4acq_A1451 Alpha-2-macroglobulin; hydrolase inhibitor, protei 98.25
3es6_B118 Prolactin-inducible protein; major histocompatibil 98.21
3dss_B331 Geranylgeranyl transferase type-2 subunit beta; pr 98.21
2hr0_B 915 Complement C3 alpha' chain; complement component C 98.2
2h6f_B437 Protein farnesyltransferase beta subunit; ftase, f 98.19
3dss_B331 Geranylgeranyl transferase type-2 subunit beta; pr 98.15
2b39_A 1661 C3; thioester, immune defense, immune system; HET: 98.01
1hzf_A367 Complement factor C4A; alpha-alpha 6 barrel, immun 97.99
2pn5_A1325 TEP1R, thioester-containing protein I; FULL-length 97.95
3cu7_A 1676 Complement C5; Mg domain, inflammation, anaphylato 97.76
4fxk_B767 Complement C4-A alpha chain; immune system, proteo 97.48
2h6f_B437 Protein farnesyltransferase beta subunit; ftase, f 97.43
2bb6_A414 TCII, TC II, transcobalamin II; alpha_6 - alpha_6 97.25
2pmv_A399 Gastric intrinsic factor; cobalamin transport prot 97.14
2icn_B118 Prolactin-inducible protein; beta-pleated sheet, c 97.12
1n4q_B377 Geranyltransferase type-I beta subunit; protein ge 96.8
3q7a_B520 Farnesyltransferase beta subunit; protein prenyltr 96.69
1n4q_B377 Geranyltransferase type-I beta subunit; protein ge 96.46
3prx_B 1642 Cobra venom factor; immune system, complement, imm 95.74
1r76_A408 Pectate lyase; A-helical structure; 2.65A {Azospir 93.76
2bb6_A414 TCII, TC II, transcobalamin II; alpha_6 - alpha_6 90.85
1gxm_A332 Pectate lyase; mechanism, elimination; 1.32A {Cell 90.73
3q7a_B520 Farnesyltransferase beta subunit; protein prenyltr 88.17
3dra_B390 Geranylgeranyltransferase type I beta subunit; ger 85.77
3dra_B390 Geranylgeranyltransferase type I beta subunit; ger 84.82
>3prx_B Cobra venom factor; immune system, complement, immune SYS complex; HET: NAG; 4.30A {Naja kaouthia} PDB: 3pvm_B* Back     alignment and structure
Probab=100.00  E-value=2.4e-96  Score=922.30  Aligned_cols=567  Identities=20%  Similarity=0.330  Sum_probs=287.8

Q ss_pred             eccceeEeeeeeEEEE-----EEEEEEeeCCCEEEEeccCCCccceeeEEeeCCcccccccccEEEEEEEEecceeeEEE
Q psy742           14 LAGQENMQSTIRSFAV-----SLSAEMAPSATIVVYNVGRNGDVIADSLTFPVNGISRNNVNATVVFLPIVPVHLGDIDV   88 (713)
Q Consensus        14 l~~~~~~~~~~~~f~~-----~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~F~I~p~~lG~i~I   88 (713)
                      +..||.+++++++|..     +|+|+|..++++|+.+..  +....|+++++.++       +++|+|+|+|+++|+++|
T Consensus       824 v~rGEq~~l~v~VfNy~~~~~~V~V~L~~s~~~~~~~~~--~~~~~q~v~v~a~~-------~~~v~f~i~p~~~G~~~i  894 (1642)
T 3prx_B          824 VVKNEQVEIRAILHNYVNEDIYVRVELLYNPAFCSASTK--GQRYRQQFPIKALS-------SRAVPFVIVPLEQGLHDV  894 (1642)
T ss_dssp             EETTCCEEEEEEEEECSSSCEEEEEEECCCTTEEESCCS--SSCCEEEEEECSSE-------EEEEEEEEEECSCEEEEE
T ss_pred             EecCCEEEEEEEEEcCCCCcEEEEEEEEcCCCeEeeccC--CCcceeEEEECCCC-------eEEEEEEEEEeecccEEE
Confidence            4589999999999987     899999999999997642  23367899999998       999999999999999999


Q ss_pred             EEEEEec--CCCceEEEEEEEecCCeEEEEeEeeeeecccc---cceeeeeeeccCCCCccCCCCc--eEEEEecC----
Q psy742           89 TVTASSL--IGRDTVTRKLHIIADGLPQHRHQSILLDLSNR---AYVFQYLHVNVTETPIIPYDVD--RYYVYGSS----  157 (713)
Q Consensus        89 ~V~A~s~--~~sD~V~~~L~V~peGv~~~~~~s~~ld~~~~---~~~~~~~~~~~p~~~~ip~s~~--~~~v~Gs~----  157 (713)
                      +|+|.+.  ..+|+|+++|+|+|||++++.+++.+|||++.   ......+.+.+|.+ .+|++..  .++|.|+.    
T Consensus       895 ~v~A~~~~~~~~D~v~k~L~V~peg~~~~~~~~~~l~~~~~~~~~~~~~~i~~~~p~~-~vpgS~~~~~vsv~gd~lg~~  973 (1642)
T 3prx_B          895 EIKASVQEALWSDGVRKKLKVVPEGVQKSIVTIVKLDPRAKGVGGTQLEVIKARKLDD-RVPDTEIETKIIIQGDPVAQI  973 (1642)
T ss_dssp             EEEEEESSSSCEEEEEEEEEEECSSEEEEEEEEEEECTTTTCSSSEEEEEECCCCCCS-BCTTCCEEEEEEEEEEC----
T ss_pred             EEEEEecCCCccceEEEEEEEecCCccEEEEEEEEEcCCcccCCcceeEEEecccccc-cCCCCcccEEEEEEcccchhh
Confidence            9999874  48899999999999999999999999999742   11233455666765 7899853  46777654    


Q ss_pred             -------CCccccccccch-------------------------------------------------------------
Q psy742          158 -------INSSSISTLKML-------------------------------------------------------------  169 (713)
Q Consensus       158 -------~~l~sLi~~P~g-------------------------------------------------------------  169 (713)
                             ++|++||+||||                                                             
T Consensus       974 i~~~l~~~~L~~Ll~~PyGCgEQnms~~~P~v~v~~yL~~t~q~~~~~~e~~~ka~~~i~~Gyqr~l~yq~~DGsfs~w~ 1053 (1642)
T 3prx_B          974 IENSIDGSKLNHLIITPSGCGEQNMIRMAAPVIATYYLDTTEQWETLGINRRTEAVNQIVTGYAQQMVYKKADHSYAAFT 1053 (1642)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             hhcccchhhHHHHHhcCCCcHHHHHHHHHHHHHHHHHHhhhccccccChhHHHHHHHHHHHHHHHHHHhcCCCCCeecCC
Confidence                   489999999998                                                             


Q ss_pred             -----hhhhhhHH---hhhhhcc-C-CCHHHHHHHHHHHHh-ccCCCcceeeccccccccccccCCCCCCCcccCcceeh
Q psy742          170 -----LWYSCLLC---LYIWETL-M-LPLQVITQAVSWVLD-HQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLT  238 (713)
Q Consensus       170 -----tWL~TAfV---F~qa~~~-~-ID~~~I~~ai~WL~~-~Q~~dG~F~e~g~v~h~~m~g~~~Gg~~~~~~~~v~LT  238 (713)
                           +|| ||||   |.+|+++ + ||+++|+++++||.+ +|++||||.|.|+++|++|+||+.|     .+++++||
T Consensus      1054 ~~~~stWL-TAyV~k~f~~A~~~i~~Vd~~~l~~~~~wL~~~~Q~~dG~F~e~~~v~~~~m~Gg~~~-----~~~~~~lT 1127 (1642)
T 3prx_B         1054 NRASSSWL-TAYVVKVFAMAAKMVAGISHEIICGGVRWLILNRQQPDGAFKENAPVLSGTMQGGIQG-----AEEEVYLT 1127 (1642)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             CCCCcccc-HHHHHHHHHHHHhhccCCCHHHHHHHHHHHHhhccCCCCcccccccccchhccCCccC-----CCCcccch
Confidence                 999 9999   9999999 8 999999999999997 8999999999999999999987754     24579999


Q ss_pred             HHHHHHHHhcccccCCCCCchhHHHHHHHHHHHHhhhhccCCCChHHHHHHHHHHHhcCCccHHHHHHHHHHhhhccCCc
Q psy742          239 AHVLITLDTVKDLTGGLGARVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKATIAEAAFGILTQHARSEGGL  318 (713)
Q Consensus       239 AyVliaL~ea~~l~~g~~~~~~~~~~kA~~yLe~~~~~~~~~~~~YtlAl~aYALaLa~~~~~~~al~~L~~~a~~~~~~  318 (713)
                      |||++||+|++.++.+.......+++||+.||+++++.+.   ++|++||+||||+|+++++ ..++++|.+.     +.
T Consensus      1128 A~vliaL~e~~~~~~~~~~~~~~~i~~a~~~L~~~~~~~~---~~Y~~Ai~aYAl~l~~~~~-~~~l~~l~~~-----~~ 1198 (1642)
T 3prx_B         1128 AFILVALLESKTICNDYVNSLDSSIKKATNYLLKKYEKLQ---RPYTTALTAYALAAADQLN-DDRVLMAAST-----GR 1198 (1642)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             HHHHHHHHhcccccccccccchHHHHHHHHHHHHhhhcCC---CHHHHHHHHHHHHhcCCch-HHHHHHHHhc-----CC
Confidence            9999999999876544333345689999999999998877   9999999999999999875 3566666543     46


Q ss_pred             eeecCCCCCCCCCCccCCCCCCCCCCCCCCCcchhhHHHHHHHHHhhcCCc-chhHHHHHHHhcccCCCCccchhhHHHH
Q psy742          319 TYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQEL-LTDPIVKWLNSQRLTDGGWASTQDTAMA  397 (713)
Q Consensus       319 ~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~VEtTAYALLa~l~~~~~-~a~~Iv~WL~~Qrn~~GGF~STQDTvvA  397 (713)
                      .||....                      ..+.+||||||||||++.++++ .+.|||+||++|||++|||+||||||+|
T Consensus      1199 ~~W~~~~----------------------~~~~~VE~TaYaLLa~l~~~~~~~a~~iv~WL~~qr~~~Ggf~STQdTvva 1256 (1642)
T 3prx_B         1199 DHWEEYN----------------------AHTHNIEGTSYALLALLKMKKFDQTGPIVRWLTDQNFYGETYGQTQATVMA 1256 (1642)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             CCCCCCC----------------------CchHHHHHHHHHHHHHhccCchhhHHHHHHHHHHhccCCCcccCcHHHHHH
Confidence            8996531                      1368999999999999999998 9999999999999999999999999999


Q ss_pred             HHHHHHHHHhcccCCcceeEEEEEEecCCCceeEEEEeccCcceeEeEEecCCCceEEEEEEeeeEEEEEEEEEEeeccc
Q psy742          398 MKALIEYTNRHRLRDVSYLTVSIEATALPGQVKYLHVKNNNLAQLQRIEIPQAWGTVKVQASGAGYAILQMSVDYNVDIA  477 (713)
Q Consensus       398 LqALa~Ya~~~~~~~~~~l~v~V~~~~~~~~~~~~~I~~~N~~~~q~~~lp~~~g~v~v~a~G~G~a~~q~~~~Yn~~~~  477 (713)
                      ||||++|+.+....+..+++|+|...+. +..++|+||.+|++++|+.+| +.+++++|+++|+||+++|+.++||+...
T Consensus      1257 LqALa~Y~~~~~~~~~~~~~V~v~~~~~-~~~~~~~v~~~N~~l~q~~~l-~~~~~~~v~a~G~G~~~~q~~~~Yn~~~~ 1334 (1642)
T 3prx_B         1257 FQALAEYEIQMPTHKDLNLDITIELPDR-EVPIRYRINYENALLARTVET-KLNQDITVTASGDGKATMTILTFYNAQLQ 1334 (1642)
T ss_dssp             --------------CCCCEEEEEECTTC-SSCEEEEESTTTSSCCEEEEE-SSCCCEEEEEEESSEEEEEEEEEEEECC-
T ss_pred             HHHHHHHHHhcCcCCCccEEEEEEeCCC-CccEEEEECCcccceeEEEEc-cCCCeEEEEEEeeeEEEEEEEEEEeccCc
Confidence            9999999998764233577888775422 245689999999999999999 47899999999999999999999998543


Q ss_pred             cccCCCCCCCeeEEEEeecc----CCCCceeEEEEEEEeeccCCCCccceEEEEEecCcceeecccchHHHhccCCCCcc
Q psy742          478 KFQTQPPVPAFALNTRANFH----GRNQSHITYHSCQRWIYQNESARSGMAVLDVAIPTGYIIQQQKLDAYIRTRNVPNL  553 (713)
Q Consensus       478 ~~~~~~~~~~F~L~v~~~~~----~~~~~~~~l~vC~~~~~~~~~~~s~MaiveV~lpSGf~~~~~~L~~l~~~~~~~~i  553 (713)
                      +  .+..++.|+|+|++...    +....++.++||++|++.   ..+|||||||+|||||+++.++|++|.. ...+.|
T Consensus      1335 ~--~~~~~~~F~L~v~~~~~~~~~~~~~~~~~l~vc~~y~~~---~~s~Mai~dV~l~SGf~~~~~~l~~L~~-~~~~~i 1408 (1642)
T 3prx_B         1335 E--KANVCNKFHLNVSVENIHLNAMGAKGALMLKICTRYLGE---VDSTMTIIDISMLTGFLPDAEDLTRLSK-GVDRYI 1408 (1642)
T ss_dssp             ------CCCSEEEEEEEECCCC-----CCEEEEEEEEEECSS---SCEEEEEEEEECCTTEEEBHHHHHHHHC-SSSEEC
T ss_pred             c--ccCCCCCEEEEEEecccccCCcccccEEEEEEEEEecCC---CCCccEEEEEecCccceechhhHHHHhh-ccccce
Confidence            2  12346789999987542    123568999999999863   4689999999999999999999999974 334578


Q ss_pred             eeEEEe-----CCEEEEEEecCCC-ceeEEEEEEEEEeeeeccccceeEEEEeccCCCceeEEEeecCc--cccccccc-
Q psy742          554 QRARFQ-----EQKVLFYFDYLDD-TETCINFTIERWFPVANMSRYLPIRVYDYYAPERFNETIFDALP--TYLLNICE-  624 (713)
Q Consensus       554 ~~~E~~-----d~~V~lYfd~l~~-~~~cv~f~~~~~~~V~~~~~pa~v~VYDYY~P~~~~~~~y~~~~--~~~~~~C~-  624 (713)
                      +|||++     +++|+||||++++ ++.||+|+++|+|+|+++ |||+|+|||||+|+++|.++|+...  ..++++|+ 
T Consensus      1409 ~~~E~~~~~~~~~~vilYld~v~~~~~~c~~f~~~q~~~V~~~-qpa~v~vYDYY~p~~~~~~~Y~~~~~~~~l~~lC~~ 1487 (1642)
T 3prx_B         1409 SRYEVDNNMAQKVAVIIYLNKVSHSEDECLHFKILKHFEVGFI-QPGSVKVYSYYNLDEKCTKFYHPDKGTGLLNKICIG 1487 (1642)
T ss_dssp             CCCCEETTEESCSEEEEEEEEECSSSCEEEEEEEEESCCCSSC-CCEEEEEEETTEEEEEEEEEEBTTBSSCCCCCEEET
T ss_pred             eEEEeeccccCCCEEEEEEccCCCCCceEEEEEEEEEEEeccc-cceEEEEEeccCCCcceEEEEcCCcCcchHHhhcCC
Confidence            999997     8899999999997 579999999999999999 6999999999999999999998643  35788886 


Q ss_pred             ---ccCCCCCCCCCC
Q psy742          625 ---VCGSSQCPYCPI  636 (713)
Q Consensus       625 ---~C~~~~C~~c~~  636 (713)
                         .|+++.|+.|..
T Consensus      1488 ~~C~Cae~~C~~~~~ 1502 (1642)
T 3prx_B         1488 NVCRCAGETCSSLNH 1502 (1642)
T ss_dssp             TEEECCCSSCCCCCC
T ss_pred             CeeEeeccCCCcccc
Confidence               378889988776



>4acq_A Alpha-2-macroglobulin; hydrolase inhibitor, proteinase inhibitor, irreversible PROT inhibitor, conformational change, blood plasma inhibitor; HET: MEQ NAG MAN; 4.30A {Homo sapiens} Back     alignment and structure
>2b39_A C3; thioester, immune defense, immune system; HET: NAG BMA; 3.00A {Bos taurus} Back     alignment and structure
>3cu7_A Complement C5; Mg domain, inflammation, anaphylatoxin, cleavage of basic residues, complement alternate pathway, glycoprotein, immune response; HET: NAG; 3.10A {Homo sapiens} PDB: 3kls_A* 3km9_A* 4e0s_A* 3prx_A* 3pvm_A* 4a5w_A* 1xwe_A Back     alignment and structure
>2hr0_B Complement C3 alpha' chain; complement component C3B, immune system; HET: THC; 2.26A {Homo sapiens} PDB: 2icf_B* 2wii_B* 2win_B* 3g6j_B 3l5n_B* 2a73_B* 2i07_B* 2xwj_B* 2xwb_B* 2a74_C* 2ice_C* 2qki_C* 3l3o_F* 3nms_C* 3nsa_C* 3ohx_C* 3t4a_C 2ice_B* 3l3o_B* 3nms_B* ... Back     alignment and structure
>2pn5_A TEP1R, thioester-containing protein I; FULL-length mature peptide, immune system; HET: NAG; 2.70A {Anopheles gambiae} Back     alignment and structure
>4fxk_B Complement C4-A alpha chain; immune system, proteolytic cascade; HET: NAG BMA; 3.60A {Homo sapiens} PDB: 4fxg_B* Back     alignment and structure
>1hzf_A Complement factor C4A; alpha-alpha 6 barrel, immune system; 2.30A {Homo sapiens} SCOP: a.102.4.4 Back     alignment and structure
>2wy7_A Complement C3D fragment; immune system, immune response, innate immunity, complement inflammatory response; 1.70A {Homo sapiens} PDB: 2wy8_A 3oed_A 3oxu_A 3rj3_A 1ghq_A* 1w2s_A Back     alignment and structure
>3hrz_C Cobra venom factor; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Naja kaouthia} PDB: 3frp_B* 3hs0_C* Back     alignment and structure
>1qqf_A Protein (complement C3DG); alpha-alpha barrel, immune system; 1.45A {Rattus norvegicus} SCOP: a.102.4.4 PDB: 1qsj_A 3d5r_A 2noj_A 2gox_A 3d5s_A 1c3d_A 2xqw_A Back     alignment and structure
>1edy_A Alpha 1-macroglobulin; beta sandwich, pseudo-symmetric dimer, protein binding; 2.30A {Rattus norvegicus} SCOP: b.2.4.1 Back     alignment and structure
>1ayo_A Alpha-2-macroglobulin; receptor binding domain; HET: NAG; 1.90A {Bos taurus} SCOP: b.2.4.1 PDB: 1bv8_A Back     alignment and structure
>4fxk_C Complement C4 gamma chain; immune system, proteolytic cascade; HET: NAG BMA; 3.60A {Homo sapiens} PDB: 4fxg_C* Back     alignment and structure
>2sqc_A Squalene-hopene cyclase; isomerase, triterpene cyclase, monotopic membrane protein, QW-sequence, repeat; HET: C8E; 2.00A {Alicyclobacillus acidocaldarius} SCOP: a.102.4.2 a.102.4.2 PDB: 3sqc_A 1ump_A* 1h35_A* 1h36_A* 1h37_A* 1h39_A* 1h3a_A* 1h3b_A* 1h3c_A* 1o6h_A* 1o6q_A* 1gsz_A* 1o79_A* 1sqc_A* 1o6r_A* Back     alignment and structure
>1w6k_A Lanosterol synthase; cyclase, cholesterol, monotopic membrane protein, B-octyl-glucoside, isomerase, steroid biosynthesis; HET: BOG LAN; 2.1A {Homo sapiens} SCOP: a.102.4.2 a.102.4.2 PDB: 1w6j_A* Back     alignment and structure
>3hrz_B Cobra venom factor; serine protease, glycosilated, multi-domain, complement SYST convertase, complement alternate pathway; HET: NAG P6G; 2.20A {Naja kaouthia} PDB: 3frp_G* 3hs0_B* Back     alignment and structure
>2wy7_A Complement C3D fragment; immune system, immune response, innate immunity, complement inflammatory response; 1.70A {Homo sapiens} PDB: 2wy8_A 3oed_A 3oxu_A 3rj3_A 1ghq_A* 1w2s_A Back     alignment and structure
>1qqf_A Protein (complement C3DG); alpha-alpha barrel, immune system; 1.45A {Rattus norvegicus} SCOP: a.102.4.4 PDB: 1qsj_A 3d5r_A 2noj_A 2gox_A 3d5s_A 1c3d_A 2xqw_A Back     alignment and structure
>1w6k_A Lanosterol synthase; cyclase, cholesterol, monotopic membrane protein, B-octyl-glucoside, isomerase, steroid biosynthesis; HET: BOG LAN; 2.1A {Homo sapiens} SCOP: a.102.4.2 a.102.4.2 PDB: 1w6j_A* Back     alignment and structure
>2sqc_A Squalene-hopene cyclase; isomerase, triterpene cyclase, monotopic membrane protein, QW-sequence, repeat; HET: C8E; 2.00A {Alicyclobacillus acidocaldarius} SCOP: a.102.4.2 a.102.4.2 PDB: 3sqc_A 1ump_A* 1h35_A* 1h36_A* 1h37_A* 1h39_A* 1h3a_A* 1h3b_A* 1h3c_A* 1o6h_A* 1o6q_A* 1gsz_A* 1o79_A* 1sqc_A* 1o6r_A* Back     alignment and structure
>4acq_A Alpha-2-macroglobulin; hydrolase inhibitor, proteinase inhibitor, irreversible PROT inhibitor, conformational change, blood plasma inhibitor; HET: MEQ NAG MAN; 4.30A {Homo sapiens} Back     alignment and structure
>3es6_B Prolactin-inducible protein; major histocompatibility complex, protein-protein complex, P inducible protein, zinc 2-glycoprotein, ZAG-PIP complex; HET: NDG NAG BMA MAN P6G; 3.23A {Homo sapiens} SCOP: b.1.18.23 Back     alignment and structure
>3dss_B Geranylgeranyl transferase type-2 subunit beta; protein prenylation, metal-binding, prenyltransferase, zinc, phosphoprotein; 1.80A {Rattus norvegicus} SCOP: a.102.4.3 PDB: 1ltx_B* 3c72_B* 1dce_B 3dst_B* 3dsu_B* 3dsv_B* 3dsw_B* 3dsx_B* 3hxb_B* 3hxc_B* 3hxd_B* 3hxe_B* 3hxf_B* 3pz1_B* 3pz2_B* 3pz3_B* 4ehm_B* 4gts_B* 4gtt_B* 4gtv_B* Back     alignment and structure
>2hr0_B Complement C3 alpha' chain; complement component C3B, immune system; HET: THC; 2.26A {Homo sapiens} PDB: 2icf_B* 2wii_B* 2win_B* 3g6j_B 3l5n_B* 2a73_B* 2i07_B* 2xwj_B* 2xwb_B* 2a74_C* 2ice_C* 2qki_C* 3l3o_F* 3nms_C* 3nsa_C* 3ohx_C* 3t4a_C 2ice_B* 3l3o_B* 3nms_B* ... Back     alignment and structure
>2h6f_B Protein farnesyltransferase beta subunit; ftase, farnesyltransferase, farnesyl transferase, prenyltransferase, CAAX, RAS, lipid modification, prenylation; HET: SUC FAR; 1.50A {Homo sapiens} SCOP: a.102.4.3 PDB: 1jcq_B* 1ld7_B* 1mzc_B* 1s63_B* 1sa4_B* 1tn6_B* 2f0y_B* 1ld8_B* 2iej_B* 3e37_B* 2h6h_B* 2h6g_B* 2h6i_B* 1o1t_B* 1o1s_B* 1o1r_B* 3eu5_B* 3pz4_B* 3e33_B* 1d8e_B* ... Back     alignment and structure
>3dss_B Geranylgeranyl transferase type-2 subunit beta; protein prenylation, metal-binding, prenyltransferase, zinc, phosphoprotein; 1.80A {Rattus norvegicus} SCOP: a.102.4.3 PDB: 1ltx_B* 3c72_B* 1dce_B 3dst_B* 3dsu_B* 3dsv_B* 3dsw_B* 3dsx_B* 3hxb_B* 3hxc_B* 3hxd_B* 3hxe_B* 3hxf_B* 3pz1_B* 3pz2_B* 3pz3_B* 4ehm_B* 4gts_B* 4gtt_B* 4gtv_B* Back     alignment and structure
>2b39_A C3; thioester, immune defense, immune system; HET: NAG BMA; 3.00A {Bos taurus} Back     alignment and structure
>1hzf_A Complement factor C4A; alpha-alpha 6 barrel, immune system; 2.30A {Homo sapiens} SCOP: a.102.4.4 Back     alignment and structure
>2pn5_A TEP1R, thioester-containing protein I; FULL-length mature peptide, immune system; HET: NAG; 2.70A {Anopheles gambiae} Back     alignment and structure
>3cu7_A Complement C5; Mg domain, inflammation, anaphylatoxin, cleavage of basic residues, complement alternate pathway, glycoprotein, immune response; HET: NAG; 3.10A {Homo sapiens} PDB: 3kls_A* 3km9_A* 4e0s_A* 3prx_A* 3pvm_A* 4a5w_A* 1xwe_A Back     alignment and structure
>4fxk_B Complement C4-A alpha chain; immune system, proteolytic cascade; HET: NAG BMA; 3.60A {Homo sapiens} PDB: 4fxg_B* Back     alignment and structure
>2h6f_B Protein farnesyltransferase beta subunit; ftase, farnesyltransferase, farnesyl transferase, prenyltransferase, CAAX, RAS, lipid modification, prenylation; HET: SUC FAR; 1.50A {Homo sapiens} SCOP: a.102.4.3 PDB: 1jcq_B* 1ld7_B* 1mzc_B* 1s63_B* 1sa4_B* 1tn6_B* 2f0y_B* 1ld8_B* 2iej_B* 3e37_B* 2h6h_B* 2h6g_B* 2h6i_B* 1o1t_B* 1o1s_B* 1o1r_B* 3eu5_B* 3pz4_B* 3e33_B* 1d8e_B* ... Back     alignment and structure
>2bb6_A TCII, TC II, transcobalamin II; alpha_6 - alpha_6 barrel, transport protein; HET: B12; 2.00A {Bos taurus} PDB: 2bbc_A* 2v3n_A* 2v3p_A* 2bb5_A* Back     alignment and structure
>2pmv_A Gastric intrinsic factor; cobalamin transport protein alpha6-alpha6 motif two domain P transport protein; HET: NAG B12; 2.60A {Homo sapiens} PDB: 3kq4_A* Back     alignment and structure
>1n4q_B Geranyltransferase type-I beta subunit; protein geranylgeranyltransferase type-I, ggtase; HET: MGM GER; 2.40A {Rattus norvegicus} SCOP: a.102.4.3 PDB: 1n4p_B* 1n4r_B* 1n4s_B* 1s64_B* 1tnb_B* 1tno_B* 1tnu_B* 1tny_B* 1tnz_B* Back     alignment and structure
>3q7a_B Farnesyltransferase beta subunit; protein prenyltransferase, transferase-transferase inhibitor; HET: SUC 3FX FPP 778; 2.00A {Cryptococcus neoformans} PDB: 3q73_B* 3q78_B* 3q79_B* 3q75_B* 3q7f_B* 3sfx_B* 3sfy_B* Back     alignment and structure
>1n4q_B Geranyltransferase type-I beta subunit; protein geranylgeranyltransferase type-I, ggtase; HET: MGM GER; 2.40A {Rattus norvegicus} SCOP: a.102.4.3 PDB: 1n4p_B* 1n4r_B* 1n4s_B* 1s64_B* 1tnb_B* 1tno_B* 1tnu_B* 1tny_B* 1tnz_B* Back     alignment and structure
>3prx_B Cobra venom factor; immune system, complement, immune SYS complex; HET: NAG; 4.30A {Naja kaouthia} PDB: 3pvm_B* Back     alignment and structure
>1r76_A Pectate lyase; A-helical structure; 2.65A {Azospirillum irakense} SCOP: a.102.5.1 Back     alignment and structure
>2bb6_A TCII, TC II, transcobalamin II; alpha_6 - alpha_6 barrel, transport protein; HET: B12; 2.00A {Bos taurus} PDB: 2bbc_A* 2v3n_A* 2v3p_A* 2bb5_A* Back     alignment and structure
>1gxm_A Pectate lyase; mechanism, elimination; 1.32A {Cellvibrio cellulosa} SCOP: a.102.5.1 PDB: 1gxn_A 1gxo_A* Back     alignment and structure
>3q7a_B Farnesyltransferase beta subunit; protein prenyltransferase, transferase-transferase inhibitor; HET: SUC 3FX FPP 778; 2.00A {Cryptococcus neoformans} PDB: 3q73_B* 3q78_B* 3q79_B* 3q75_B* 3q7f_B* 3sfx_B* 3sfy_B* Back     alignment and structure
>3dra_B Geranylgeranyltransferase type I beta subunit; geranylgeranyltrasferase, ggtase, ggtase-I, PGGT, prenyltransferase, farnesyltransferase; HET: B3P GRG; 1.80A {Candida albicans} Back     alignment and structure
>3dra_B Geranylgeranyltransferase type I beta subunit; geranylgeranyltrasferase, ggtase, ggtase-I, PGGT, prenyltransferase, farnesyltransferase; HET: B3P GRG; 1.80A {Candida albicans} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 713
d1hzfa_326 a.102.4.4 (A:) C4adg fragment of complement factor 2e-35
d1c3da_294 a.102.4.4 (A:) C3D, a C3 fragment and ligand for c 2e-28
d1ayoa_130 b.2.4.1 (A:) alpha-2-macroglobulin {Cow (Bos tauru 2e-24
d1edya_134 b.2.4.1 (A:) alpha-1-macroglobulin {Rat (Rattus no 3e-24
d1w6ka1448 a.102.4.2 (A:6-99,A:379-732) Lanosterol synthase { 4e-05
d2sqca1352 a.102.4.2 (A:8-36,A:308-630) Squalene-hopene cycla 0.002
>d1hzfa_ a.102.4.4 (A:) C4adg fragment of complement factor C4a {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure

class: All alpha proteins
fold: alpha/alpha toroid
superfamily: Terpenoid cyclases/Protein prenyltransferases
family: Complement components
domain: C4adg fragment of complement factor C4a
species: Human (Homo sapiens) [TaxId: 9606]
 Score =  134 bits (338), Expect = 2e-35
 Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 16/225 (7%)

Query: 189 QVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITLDTV 248
           + + +  +W+L  Q  DGSF +   ++DR +   L   ++      ++LTA V I L   
Sbjct: 103 EKLQETSNWLLSQQQADGSFQDPCPVLDRSMQGGLVGNDET-----VALTAFVTIALHHG 157

Query: 249 KDLTGGLGA-----RVSLAQSKAIKWLERNLRLLKDFGDPYEVAIVAYALRLSKA--TIA 301
             +    GA     RV  + SKA  +L             +  AI AYAL L+KA   + 
Sbjct: 158 LAVFQDEGAEPLKQRVEASISKASSFLGEKAS--AGLLGAHAAAITAYALTLTKAPADLR 215

Query: 302 EAAFGILTQHARSEGGLTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALL 361
             A   L   A+  G   YWG        +      P        +  A+ IETTAYALL
Sbjct: 216 GVAHNNLMAMAQETGDNLYWGSVTGSQSNAVSPTPAPRNPSDPMPQAPALWIETTAYALL 275

Query: 362 VYVSRQELLT--DPIVKWLNSQRLTDGGWASTQDTAMAMKALIEY 404
             +  +      D    WL  Q    GG+ STQDT +A+ AL  Y
Sbjct: 276 HLLLHEGKAEMADQASAWLTRQGSFQGGFRSTQDTVIALDALSAY 320


>d1c3da_ a.102.4.4 (A:) C3D, a C3 fragment and ligand for complement receptor 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 294 Back     information, alignment and structure
>d1ayoa_ b.2.4.1 (A:) alpha-2-macroglobulin {Cow (Bos taurus) [TaxId: 9913]} Length = 130 Back     information, alignment and structure
>d1edya_ b.2.4.1 (A:) alpha-1-macroglobulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 134 Back     information, alignment and structure
>d1w6ka1 a.102.4.2 (A:6-99,A:379-732) Lanosterol synthase {Human (Homo sapiens) [TaxId: 9606]} Length = 448 Back     information, alignment and structure
>d2sqca1 a.102.4.2 (A:8-36,A:308-630) Squalene-hopene cyclase {Alicyclobacillus acidocaldarius [TaxId: 405212]} Length = 352 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query713
d1hzfa_326 C4adg fragment of complement factor C4a {Human (Ho 100.0
d1c3da_294 C3D, a C3 fragment and ligand for complement recep 99.97
d1edya_134 alpha-1-macroglobulin {Rat (Rattus norvegicus) [Ta 99.96
d1ayoa_130 alpha-2-macroglobulin {Cow (Bos taurus) [TaxId: 99 99.96
d1w6ka1448 Lanosterol synthase {Human (Homo sapiens) [TaxId: 99.09
d2sqca1352 Squalene-hopene cyclase {Alicyclobacillus acidocal 99.02
d2sqca1352 Squalene-hopene cyclase {Alicyclobacillus acidocal 98.84
d1w6ka1448 Lanosterol synthase {Human (Homo sapiens) [TaxId: 98.15
d3es6b1118 Prolactin-inducible protein, PIP {Human (Homo sapi 97.99
d1c3da_294 C3D, a C3 fragment and ligand for complement recep 97.97
d1hzfa_326 C4adg fragment of complement factor C4a {Human (Ho 97.92
d2sqca2271 Squalene-hopene cyclase {Alicyclobacillus acidocal 97.78
d3dssb1325 Rab geranylgeranyltransferase, beta subunit {Rat ( 97.64
d3dssb1325 Rab geranylgeranyltransferase, beta subunit {Rat ( 96.89
d2h6fb1401 Protein farnesyltransferase, beta-subunit {Human ( 96.51
d1w6ka2279 Lanosterol synthase {Human (Homo sapiens) [TaxId: 94.52
d1n4qb_346 Protein farnesyltransferase, beta-subunit {Rat (Ra 94.09
d2sqca2271 Squalene-hopene cyclase {Alicyclobacillus acidocal 92.49
d1n4qb_346 Protein farnesyltransferase, beta-subunit {Rat (Ra 92.44
d1r76a_408 Polygalacturonic acid lyase (pectate lyase) {Azosp 89.84
d2h6fb1401 Protein farnesyltransferase, beta-subunit {Human ( 86.6
>d1hzfa_ a.102.4.4 (A:) C4adg fragment of complement factor C4a {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: All alpha proteins
fold: alpha/alpha toroid
superfamily: Terpenoid cyclases/Protein prenyltransferases
family: Complement components
domain: C4adg fragment of complement factor C4a
species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00  E-value=1e-36  Score=324.06  Aligned_cols=231  Identities=29%  Similarity=0.364  Sum_probs=177.9

Q ss_pred             hhhhhhHH---hhhhhcc-CCCHHHHHHHHHHHHhccCCCcceeeccccccccccccCCCCCCCcccCcceehHHHHHHH
Q psy742          170 LWYSCLLC---LYIWETL-MLPLQVITQAVSWVLDHQTPDGSFYETTWLVDRKVNSSLNWPNDDVKFRNISLTAHVLITL  245 (713)
Q Consensus       170 tWL~TAfV---F~qa~~~-~ID~~~I~~ai~WL~~~Q~~dG~F~e~g~v~h~~m~g~~~Gg~~~~~~~~v~LTAyVliaL  245 (713)
                      +|| ||||   |.+|+++ ++|++.+++++.|++++|..+|+|.+.++++|..++++..+     ....+.+||||+++|
T Consensus        81 ~wl-Tayv~~~L~~A~~~g~~~~~~~~~~~~~~l~~q~~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~tAyvl~aL  154 (326)
T d1hzfa_          81 TWL-TAFVLKVLSLAQEQVGGSPEKLQETSNWLLSQQQADGSFQDPCPVLDRSMQGGLVG-----NDETVALTAFVTIAL  154 (326)
T ss_dssp             HHH-HHHHHHHHHHHGGGTCCCHHHHHHHHHHHGGGBCTTSCBCCSSCCSCGGGGGGGSS-----TTHHHHHHHHHHHHH
T ss_pred             hHH-HHHHHHHHHHHHHhcccchhhHHhHHHHHHHHhhhcccccccccccCHHHhccccc-----cccchhHHHHHHHHH
Confidence            999 9999   8999999 99999999999999999999999999999999999876543     245688999999999


Q ss_pred             HhcccccCCCC-----CchhHHHHHHHHHHHHhhhh-ccCCCChHHHHHHHHHHHhcCCccH--HHHHHHHHHhhhccCC
Q psy742          246 DTVKDLTGGLG-----ARVSLAQSKAIKWLERNLRL-LKDFGDPYEVAIVAYALRLSKATIA--EAAFGILTQHARSEGG  317 (713)
Q Consensus       246 ~ea~~l~~g~~-----~~~~~~~~kA~~yLe~~~~~-~~~~~~~YtlAl~aYALaLa~~~~~--~~al~~L~~~a~~~~~  317 (713)
                      .+++....+..     .++..++.||++||+++... +.   ++|++|+++|||+++++.+.  ..++++|++.+..+++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~i~kA~~~l~~~~~~~~~---~~y~~a~~a~al~~~~~~~~~~~~~~~~l~~~a~~~~~  231 (326)
T d1hzfa_         155 HHGLAVFQDEGAEPLKQRVEASISKASSFLGEKASAGLL---GAHAAAITAYALTLTKAPADLRGVAHNNLMAMAQETGD  231 (326)
T ss_dssp             HHHHTTCCTTTTHHHHHHHHHHHHHHHHHHHHHHHHTCC---CHHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTCEECSS
T ss_pred             HHcccccccchhhhhHhhHHHHHHHHHHHHHHHhhcccC---CHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHhhccc
Confidence            99875332221     12345689999999998753 45   99999999999999998763  4567788888888888


Q ss_pred             ceeecCCCCCCCCCCccCCCCCCCCCCCCCCCcchhhHHHHHHHHHhhcCC-c-chhHHHHHHHhcccCCCCccchhhHH
Q psy742          318 LTYWGKEPVPAPPSKIENQKPFLLPRLPYKYDAINIETTAYALLVYVSRQE-L-LTDPIVKWLNSQRLTDGGWASTQDTA  395 (713)
Q Consensus       318 ~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~VEtTAYALLa~l~~~~-~-~a~~Iv~WL~~Qrn~~GGF~STQDTv  395 (713)
                      ..||..............+..+..++..++..+.+|||||||||+++..+. . .+.++++||.+||+.+|||.|||||+
T Consensus       232 ~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~iettayaLla~~~~~~~~~~~~~~~~WL~~qr~~~Ggw~STQdT~  311 (326)
T d1hzfa_         232 NLYWGSVTGSQSNAVSPTPAPRNPSDPMPQAPALWIETTAYALLHLLLHEGKAEMADQASAWLTRQGSFQGGFRSTQDTV  311 (326)
T ss_dssp             CEECC------------------------CCCHHHHHHHHHHHHHHHHHTCSSHHHHHHHHHHHHHTTSTTCSCSHHHHH
T ss_pred             cceecccccccccccccccccccCCCCCcccchHHHHHHHHHHHHHHhcCCCchhHHHHHHHHHHhccCCCCCccHHHHH
Confidence            899976442211111111111111122223467899999999999998754 4 88999999999999999999999999


Q ss_pred             HHHHHHHHHHHhcc
Q psy742          396 MAMKALIEYTNRHR  409 (713)
Q Consensus       396 vALqALa~Ya~~~~  409 (713)
                      +||+||++|+.+++
T Consensus       312 ~al~AL~~y~~~~~  325 (326)
T d1hzfa_         312 IALDALSAYWIASH  325 (326)
T ss_dssp             HHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHhc
Confidence            99999999998764



>d1c3da_ a.102.4.4 (A:) C3D, a C3 fragment and ligand for complement receptor 2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1edya_ b.2.4.1 (A:) alpha-1-macroglobulin {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1ayoa_ b.2.4.1 (A:) alpha-2-macroglobulin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1w6ka1 a.102.4.2 (A:6-99,A:379-732) Lanosterol synthase {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2sqca1 a.102.4.2 (A:8-36,A:308-630) Squalene-hopene cyclase {Alicyclobacillus acidocaldarius [TaxId: 405212]} Back     information, alignment and structure
>d2sqca1 a.102.4.2 (A:8-36,A:308-630) Squalene-hopene cyclase {Alicyclobacillus acidocaldarius [TaxId: 405212]} Back     information, alignment and structure
>d1w6ka1 a.102.4.2 (A:6-99,A:379-732) Lanosterol synthase {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3es6b1 b.1.18.23 (B:1-118) Prolactin-inducible protein, PIP {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1c3da_ a.102.4.4 (A:) C3D, a C3 fragment and ligand for complement receptor 2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1hzfa_ a.102.4.4 (A:) C4adg fragment of complement factor C4a {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2sqca2 a.102.4.2 (A:37-307) Squalene-hopene cyclase {Alicyclobacillus acidocaldarius [TaxId: 405212]} Back     information, alignment and structure
>d3dssb1 a.102.4.3 (B:7-331) Rab geranylgeranyltransferase, beta subunit {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d3dssb1 a.102.4.3 (B:7-331) Rab geranylgeranyltransferase, beta subunit {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2h6fb1 a.102.4.3 (B:521-921) Protein farnesyltransferase, beta-subunit {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w6ka2 a.102.4.2 (A:100-378) Lanosterol synthase {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1n4qb_ a.102.4.3 (B:) Protein farnesyltransferase, beta-subunit {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2sqca2 a.102.4.2 (A:37-307) Squalene-hopene cyclase {Alicyclobacillus acidocaldarius [TaxId: 405212]} Back     information, alignment and structure
>d1n4qb_ a.102.4.3 (B:) Protein farnesyltransferase, beta-subunit {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1r76a_ a.102.5.1 (A:) Polygalacturonic acid lyase (pectate lyase) {Azospirillum irakense [TaxId: 34011]} Back     information, alignment and structure
>d2h6fb1 a.102.4.3 (B:521-921) Protein farnesyltransferase, beta-subunit {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure